WO2018105255A1 - Method and apparatus both for producing cell aggregate structure - Google Patents

Method and apparatus both for producing cell aggregate structure Download PDF

Info

Publication number
WO2018105255A1
WO2018105255A1 PCT/JP2017/038129 JP2017038129W WO2018105255A1 WO 2018105255 A1 WO2018105255 A1 WO 2018105255A1 JP 2017038129 W JP2017038129 W JP 2017038129W WO 2018105255 A1 WO2018105255 A1 WO 2018105255A1
Authority
WO
WIPO (PCT)
Prior art keywords
cell
culture
cell aggregate
pin
aggregate
Prior art date
Application number
PCT/JP2017/038129
Other languages
French (fr)
Japanese (ja)
Inventor
健二 米田
一朗 越田
Original Assignee
澁谷工業株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 澁谷工業株式会社 filed Critical 澁谷工業株式会社
Publication of WO2018105255A1 publication Critical patent/WO2018105255A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M3/00Tissue, human, animal or plant cell, or virus culture apparatus

Definitions

  • the present invention relates to a method and apparatus for producing a cell aggregate structure, and more specifically, a plurality of cell aggregates are arranged inside a culture vessel containing a culture solution, and the plurality of cell aggregates are cultured and fused together.
  • the present invention relates to a method and apparatus for manufacturing a cell aggregate structure.
  • Patent Document 1 In regenerative medicine in which damaged biological functions are restored using stem cells or the like, cell sheets in which cells are cultured at high density are used. Since this cell sheet is extremely thin, a method for producing a laminated cultured cell sheet in which several cell sheets are superposed is known (Patent Document 1). In addition, in the method for producing a laminated cultured cell sheet in which such cell sheets are superposed, hydrogel particles are arranged between the laminated cell sheets so that oxygen, nutrients, etc. are applied to the cells in the laminated part. A method for producing a cell sheet more reliably is also known (Patent Document 2).
  • cell aggregates in which cells have been cultured in a substantially spherical shape are arranged in contact with each other and subjected to suspension culture to produce a sheet-like cell aggregate having a thickness of 50 to 300 ⁇ m in which the cell aggregates are fused.
  • a method is also known (Patent Document 3).
  • Patent Documents 1 and 2 when cell sheets are laminated as in Patent Documents 1 and 2, since the cell sheets are extremely thin, handling is difficult and it is difficult to automate, and cell aggregates are suspended and cultured as in Patent Document 3
  • the density of the aligned cell aggregate is generated and the cell aggregate aggregates irregularly, so the shape of the resulting sheet-like cell aggregate is not determined, There was a problem that the thickness became non-uniform.
  • the present invention can obtain a required shape and size, and can add functionality, and a method and apparatus for manufacturing a cell aggregate structure corresponding to automation Is to provide.
  • a plurality of cell aggregates are arranged inside a culture vessel containing a culture solution, and the plurality of cell aggregates are cultured and fused to each other.
  • a supply step of holding a cell aggregate in a holding part constituted by a plurality of pins erected inside the culture vessel, and culturing the cell aggregate held in an adjacent holding part to form the aggregate structure A culturing step to be formed, a detaching step of taking out the aggregate structure formed in the culturing step from the holding portion, and injecting an injection into a through-hole by the pin opening in the aggregate structure taken out in the detaching step And an injection step.
  • an apparatus for producing a cell aggregate structure in which a plurality of cell aggregates are arranged inside a culture vessel containing a culture solution, and the plurality of cell aggregates are cultured and fused together.
  • a culture holder provided inside the culture vessel and provided with a plurality of pins, a supply means for holding a cell aggregate in a plurality of holding parts constituted by the pins of the culture holder, and the culture holder
  • the detachment means for taking out the aggregate structure formed by culturing the cell agglomerates held in the cell from the holding part of the culture holder, and the injection into the through-hole by the pin opening to the extracted aggregate structure
  • injection means for injecting is provided.
  • each cell agglomeration is held by a plurality of adjacent holding portions with a plurality of pins provided in the culture holder as a holding portion.
  • the clumps are fused with each other by being cultured in the holding part, and a cell aggregate structure having a required shape and size can be produced, and this can be automated.
  • the through-hole is formed in the aggregate structure of the cells cultured in this way by the pins constituting the holding portion, functionality is added by injecting an injection into the through-hole. An aggregate structure of cells can be produced.
  • FIG. 1 Front view of an isolator and an incubator provided with an apparatus for manufacturing a cell aggregate structure
  • Configuration diagram of cell assembly structure manufacturing equipment Cross-sectional view of the storage container and suction nozzle Cross section of culture vessel Plan view of cell clumps placed in the culture vessel It is sectional drawing about an injection nozzle, Comprising: The figure explaining the injection
  • FIGS. 1 to 6 illustrate a cell aggregate structure manufacturing apparatus 1 according to the first embodiment, which includes a plurality of cell aggregates 2 (spheroids: see FIG. 3). ) Is placed inside the culture vessel 3, and the cell aggregate 2 is cultured to produce a fusion pad 4 (see FIG. 4) as an aggregate structure of cells fused together.
  • the cell aggregate 2 can be produced by, for example, a method disclosed in Japanese Patent No. 4517125. That is, when cells are seeded and cultured in a container whose inner surface is non-adhesive, the cells aggregate to form a cell aggregate 2 by adhering to each other in search of a scaffold, and these further fuse to form an outer diameter.
  • a substantially spherical cell aggregate 2 having a dimension of about 500 ⁇ m is formed. More efficiently, the cell aggregate 2 can be easily obtained by culturing in a non-adhesive well (substantially hemispherical accommodating portion) of the well plate.
  • the method for producing the cell agglomerate 2 is not limited to this, and a swirl culture method in which the cell suspension is put in the swirling culture solution, or a method in which the cell suspension is put in a test tube and precipitated with a centrifuge Alternatively, it can be prepared by various known methods such as a culture method using alginate beads.
  • the cell aggregate 2 refers to a substantially spherical cell aggregate having an outer diameter of about 100 to 700 ⁇ m in which cells are aggregated and aggregated. These cell aggregates 2 are planar or three-dimensional. If the cells are placed in contact or close to each other, the cells of each cell aggregate 2 proliferate and fuse with the adjacent cell aggregate 2 to obtain a planar or three-dimensional aggregate structure of cells. .
  • the fusion pad 4 produced in the present embodiment is made from, for example, tissues such as bone, muscle, internal organs, blood vessels, skin, organs, somatic cells constituting the organs, precursor cells thereof, stem cells, etc., and bone or cartilage defects. It is intended to be used by filling the part or pasting it on the surface of an organ or organ.
  • the above-mentioned fusion pad 4 is obtained by arranging a plurality of cell aggregates 2 in a plane and fusing them, and a thickness of about 100 to 700 ⁇ m is produced according to the size of the cell aggregates 2 to be used.
  • the planar size can be adjusted by the number of cell aggregates 2 to be aligned.
  • the fusion pad 4 thus produced is different from a cell sheet obtained by culturing a cell suspension in a planar form by culturing a cell suspension in a planar manner.
  • the cell assembly structure manufacturing apparatus 1 of the present embodiment is provided inside an isolator 5 in which the interior shown in FIG. 1 is maintained in a sterile state and an incubator 6 provided so as to be connectable to the isolator 5. Yes.
  • the isolator 5 is provided with a pass box 5a for decontaminating the incoming material.
  • FIG. 2 shows a configuration provided inside the isolator 5, and a container supporting unit 8 that supports the container 7 that stores the cell aggregate 2 and a culture that supports the culture container 3 in which the fusion pad 4 is cultured.
  • An injection nozzle 12 as injection means for injecting an injection into the fusion pad 4 and an injection nozzle moving means 13 for moving the injection nozzle 12 relative to the culture vessel 3 are provided.
  • the horizontal direction shown in FIG. 2 is the X direction
  • the front-rear direction is the Y direction
  • the vertical direction is the Z direction
  • the horizontal direction is the X direction and the vertical direction is the Y direction.
  • the interior of the isolator 5 is maintained in a sterile environment, and a one-way flow is generated by aseptic air from above to below by the sterile air supply means.
  • a glove 5b that can be worn by an operator is provided in front of the isolator 5, so that various operations can be performed. It is also possible to provide a robot or a transfer means having a required configuration inside the isolator 5 so that these operations are automatically performed.
  • the inside of the incubator 6 is maintained in a sterile environment and is maintained at a predetermined temperature and humidity suitable for culturing the fusion pad 4, and the cell aggregate 2 is fused to form the fusion pad 4.
  • the incubator 6 can be separated from the isolator 5 and placed at a location away from the isolator 5. Therefore, the isolator 5 and the incubator 6 are connected by the connecting means 5c.
  • the connecting means for contacting and separating the incubator 6 and the isolator 5 while maintaining the sterility. can be used.
  • FIG. 3 shows a cross-sectional view of the container 7, and the well plate described above can be used.
  • the storage container 7 includes a plurality of storage recesses 7a vertically and horizontally in a plan view, and each of the storage recesses 7a stores a substantially spherical cell aggregate 2 together with a culture solution one by one.
  • the storage recesses 7a of the storage container 7 are arranged in a predetermined number in the X direction and the Y direction in plan view.
  • the X of the cell aggregate 2 constituting the fusion pad 4 produced in the culture container 3 is used.
  • the number is the same as the number in the direction and the Y direction, that is, five in the X direction and five in the Y direction.
  • the storage container support 8 that supports the storage container 7 is configured by a Y-direction table 8a that constitutes the suction nozzle moving means 11 while positioning the storage container 7 on the upper surface thereof by a positioning piece 8b.
  • a Y-direction table 8a that constitutes the suction nozzle moving means 11 while positioning the storage container 7 on the upper surface thereof by a positioning piece 8b.
  • five suction nozzles 10 of the present embodiment are provided in the X direction, and are movable only in the X direction and the Z direction. Therefore, the Y direction table 8a moves the container 7 in the Y direction.
  • the suction nozzle 10 and the container 7 can be relatively moved in each direction of XYZ.
  • the Y-direction table 8a first positions the first row of storage recesses 7a of the storage container 7 below the suction nozzle 10, and the suction nozzle 10 aggregates cells from the first row of storage recesses 7a.
  • the Y-direction table 8a moves the storage container 7 in the Y direction by one row, and the second row of storage recesses 7a is positioned below the suction nozzle 10.
  • the culture vessel 3 has a bottomed box shape, in which a culture solution is accommodated at a predetermined depth, and a bottom plate 14 installed on the bottom surface, and the bottom plate 14 and a culture holder comprising a plurality of pins 16 erected on the pedestal 15 and a support plate 17 as a support member that moves up and down along the pins 16 are provided.
  • the bottom plate 14 has substantially the same shape as the bottom surface of the culture vessel 3 and is positioned so that the bottom plate 14 does not move inside the culture vessel 3.
  • the pedestal 15 has a rectangular parallelepiped shape, and is positioned by being fitted into a recess 14 a formed on the upper surface of the bottom plate 14.
  • FIG. 5 shows a plan view of the pin 16 provided on the pedestal 15 and the cell aggregate 2 held by the pin 16, and in this embodiment, five cell aggregates 2 in the X direction and Y direction, respectively. Are arranged in a plane in contact with each other.
  • the pin 16 is provided so as to be located around each cell aggregate 2, and in this embodiment, the holding part H that holds the cell aggregate 2 is configured by four pins 16. More specifically, a substantially square section where the four pins 16 are located at the four corners in plan view is the holding portion H.
  • the interval between the two pins 16 at each diagonal position is arranged to be shorter than the diameter of the cell aggregate 2 to be held. ing.
  • the diameter is made larger than the interval between the two pins 16 at each diagonal position.
  • the holding portion H can be set at a position separated from the installation surface 15a where the plurality of pins 16 are erected, and between the cell aggregate 2 held by the holding portion H and the installation surface 15a.
  • a gap g through which the culture solution can be circulated can be formed.
  • the cell aggregates 2 of the holding portions H are brought into contact with each other by making the interval between the two pins 16 at the diagonal positions shorter than the diameter of the cell aggregate 2. It can be cultured in a state of being allowed to stand.
  • the bottom plate 14 is provided with two rod-shaped guide members 18 which are provided at positions opposed to each other with the pedestal 15 interposed therebetween and which are erected in the Z direction and penetrate the support plate 17 up and down.
  • the support plate 17 has a through hole 17a through which the pin 16 passes.
  • the culture solution is interposed between the cell aggregate 2 held on the upper and lower intermediate portions of the pin 16 and the installation surface 15a of the pedestal 15.
  • circulated is formed.
  • the support plate 17 when the support plate 17 is raised, the support plate 17 can support the cell aggregate 2 held between the pins 16 and 16 from below, Since the support plate 17 is positioned up to the ascending position on the tip side of the pin 16, the fusion pad 4 on which the cell aggregate 2 is cultured can be taken out from the holding portion H between the pins 16. Yes.
  • the support plate 17 can be raised by an operator wearing the globe 5b, or by a robot or the like. At this time, although not shown, by providing a grip member protruding above the surface of the culture solution on the upper surface of the support plate 17, the support plate 17 can be raised without touching the culture solution.
  • the culture vessel support portion 9 is constituted by a Y-direction table 9 a that constitutes the suction nozzle moving means 11, and is similar to the Y-direction table 8 a that constitutes the storage vessel support portion 8.
  • the holding part H constituted by the pin 16 Each time the adsorbed and held cell aggregate 2 is supplied to the holding part H constituted by the pin 16, the holding part H set between the pins 16 together with the culture vessel 3 is moved in a row in the Y direction. It has become.
  • a main body portion 10a connected to a negative pressure generating means (not shown) and a tubular suction portion 10b provided at the lower end portion of the main body portion 10a.
  • the inner diameter of the adsorbing portion 10b is smaller than that of the cell aggregate 2 and when the cell aggregate 2 is adsorbed and held at the tip of the adsorbing portion 10b in the accommodating recess 7a of the accommodating container 7, the cell aggregate 2 The suction portion 10b is not sucked into the interior.
  • the center position of the adsorbing portion 10 b is positioned at the approximate center of the holding portion H formed between the pin 16 and the pin 16, and the cell aggregate 2 is positioned at the upper and lower intermediate positions of the pin 16.
  • the negative pressure by the negative pressure generating means is eliminated in the positioned state.
  • the cell aggregate 2 may be held using a structure having a configuration such as holding the cell aggregate 2 with a gripper or the like.
  • the suction nozzle moving means 11 for moving the suction nozzle 10 includes an X-direction rail 21 provided in the X direction over the storage container support 8 and the culture container support 9, and a suction nozzle along the X-direction rail 21.
  • the unit 9 is composed of the Y-direction tables 8a and 9a.
  • the suction nozzle moving means 11 may be configured to move the X-direction rail 21 in the Y direction instead of the Y-direction tables 8a and 9a. With such a configuration, the suction nozzle 10, the injection nozzle 12, and the camera 25 described later can be moved in the XY direction.
  • five suction nozzles 10 are arranged in the X direction, and the intervals of these suction nozzles 10 are changed in the X direction by the interval changing means 24.
  • the interval changing means 24 is arranged at the same interval as the storage recesses 7 a aligned in the X direction in the storage container 7. Change the interval.
  • the suction nozzle 10 is positioned above the culture vessel support 9, the interval changing means 24 is set to X in the holding portion H formed between the pins 16 inside the culture vessel 3. The interval of the suction nozzle 10 is changed to the same interval as the direction interval.
  • the suction nozzles 10 can be provided in a plurality of rows in the Y direction, and the interval between the accommodation recesses 7a of the accommodation container support 8 and the holding portion H formed between the pins 16 and 16 can be provided.
  • the interval changing means 24 can be omitted.
  • the interval between the holding portions H is narrow, it is possible to hold the cell aggregate 2 in every other holding portion H by the suction nozzle 10, and in this case, the odd-numbered holding portions are initially set.
  • the cell aggregate 2 may be held by H, and then the cell aggregate 2 may be held by the even-numbered holding part H.
  • At least one suction nozzle 10 is provided, and as a means for supplying the cell aggregate 2, in addition to the configuration for transferring the cell aggregate 2 as in this embodiment, a number of cell aggregates are provided.
  • the configuration may be such that one by one is delivered from the container containing the lump 2.
  • the injection nozzle 12 includes a main body portion 12a connected to an injection supply means (not shown) and a tubular injection portion 12b provided at the lower end of the main body portion 12a.
  • the injection is injected into the through-hole 4a opened in the fusion pad 4 thus cultured.
  • nutritional components that promote cell culture as injections, engraftment and growth after transplantation of the fusion pad 4 to a patient, growth factors and growth factors that promote regeneration of surrounding tissues, blood vessel A cell suspension that promotes neoplasia, a drug that acts on the living body after transplantation, and the like are supplied in the form of a liquid, gel, gel, particle, granule, and the like.
  • the injection may be performed above the through hole 4a, or may be performed by inserting the injection nozzle 12 into the through hole 4a.
  • the injection can be embedded in the fusion pad 4, and a larger amount of the injection than in the case where the injection is simply dropped on the surface of the fusion pad 4 4 can penetrate.
  • poured it may culture
  • the injection nozzle moving means 13 for moving the injection nozzle 12 includes an X-direction rail 21 that is used in common with the suction nozzle movement means 11, a left-right movement means 25 that moves along the X-direction rail 21,
  • the moving unit 25 includes a vertical moving unit 26 that moves the injection nozzle 12 up and down in the Z direction, and the Y direction table 9 a in the culture vessel support 9.
  • the injection nozzle moving means 13 may be configured not to include the Y-direction table 9a but to move the injection nozzle 12 in the X direction and the Y direction. it can. It is also possible to inject different injections by providing a plurality of injection nozzles 12 and moving them individually.
  • the X-direction rail 21 is provided with a camera 28 in a lateral movement means 27 that moves in the X direction, and the camera 28 is moved to above the culture vessel support 9 to photograph the inside of the culture vessel 3. It has become.
  • the cell aggregate 2 is held in the holding part H by the suction nozzle 10
  • the injection is injected into the fusion pad 4 by the injection nozzle 12, the position of the through hole 4a of the fusion pad 4 is recognized from the image taken by the camera 28.
  • the camera 28 is also used when the suction nozzle moving means 11 positions the suction nozzle 10 above the culture vessel support 9 and when the injection nozzle movement means 13 positions the injection nozzle 12 above the culture vessel support 9. In order to avoid contact with these, they are retracted from above the culture vessel support 9.
  • the culture vessel 3 is provided with a culture holder comprising the pedestal 15 and a plurality of pins 16, and the support plate 17 is located at a lowered position in contact with the installation surface 15 a of the pedestal 15 by its own weight.
  • the preparation step if a plurality of the storage containers 7 and culture containers 3 are carried into the isolator 5, a plurality of fusion pads 4 can be continuously produced using the plurality of culture containers 3.
  • the cell aggregate 2 is subsequently moved from the container 7 to the culture vessel 3 by the suction nozzle 10, and the cells are placed in the holding part H set by the pins 16 of the culture vessel 3.
  • a supplying step for supplying the aggregate 2 is performed.
  • the suction nozzle moving means 11 moves the suction nozzle 10, and the interval changing means 24 changes the interval of the suction nozzle 10, so that the cell aggregate 2 is removed from the accommodating recess 7 a of the accommodating container 7 in the accommodating container support 8. Hold by adsorption.
  • the suction nozzle moving means 11 moves the suction nozzle 10 to the culture vessel support portion 9, and the interval changing means 24 is adjusted to the interval of the holding portion H formed between the pins 16 and 16.
  • the interval of the suction nozzle 10 is changed, and the suction nozzle 10 is lowered. Then, each cell aggregate 2 held by the suction nozzle 10 is inserted into the holding portion H formed between the four pins 16, and the pin g is formed so that a gap g is formed below the cell aggregate 2.
  • the cell aggregate 2 is held at 16 upper and lower intermediate positions.
  • the culture container 3 is transferred to the incubator 6 by a robot or an operator's manual operation, and the cell aggregate 2 in the culture container 3 is removed.
  • a culture step of culturing is performed. First, when the culture vessel 3 is transferred to the incubator 6, the incubator 6 is separated from the isolator 5 and placed at a position separated from the isolator 5 to maintain the inside at a predetermined temperature and humidity, and a predetermined carbon dioxide gas. And maintain oxygen concentration.
  • the cell aggregates 2 of the adjacent holding portions H are fused with each other, so that the cell aggregate 2 is maintained in a planar arrangement.
  • the fusion pad 4 as a collective structure can be obtained.
  • the size of the formed fusion pad 4 can be made substantially the same as the size when the cell aggregate 2 is first arranged, It becomes possible to produce the fusion pad 4 having any shape as the cell aggregate 2 is arranged. This is because the cell aggregate 2 grows or moves so as to be in close contact with the periphery of the pin 16 in contact with the cell aggregate 2 and fills the gap formed between the adjacent cell aggregates 2. As in the case where the cell agglomerates 2 are arranged in a plane and cultured without intervention, the overall dimensions hardly shrink.
  • the culture solution is supplied between the fusion pad 4 and the installation surface 15 a of the pedestal 15, and the back side of the fusion pad 4. Can also be efficiently cultured. That is, when the fusion pad 4 is produced by placing the cell aggregate 2 on the installation surface 15a, there is a problem that the culture solution does not sufficiently spread to the lower surface side of the cell aggregate 2 located in the center. By holding the cell aggregate 2 in a state in which the gap g is formed below, the cells located in the part can be well cultured. If the support plate 17 is moved up and down during the culture, the flow of the culture solution is promoted, which is more effective.
  • the incubator 6 is connected to the isolator 5, the culture vessel 3 is placed on the culture vessel support portion 9 inside the isolator 5, and the support plate 17 positioned at the lowered position is raised by an operator or a robot or the like. To position.
  • the fusion pad 4 is raised along the pins 16 and the support plate 17 is lifted upward as shown in FIG. 4B.
  • the support plate 17 is fixed with a fixture 17b such as a clip.
  • the fusion pad 4 is positioned above the pin 16 by fixing or by gently moving the support plate 17 to the lowered position and supporting the fusion pad 4 from below by the tip of the pin 16.
  • an injection process for injecting an injection into the through-hole 4a by the pin 16 that is opened to the fusion pad 4 by the injection nozzle 12 is performed. .
  • the camera 28 moves above the culture vessel support 9 to photograph the fusion pad 4 in the culture vessel 3 and recognize the position of the through hole 4 a of the fusion pad 4.
  • the injection nozzle moving means 13 moves the injection nozzle 12 above the culture vessel support 9 and further positioned above the through-hole 4a of the fusion pad 4, as shown in FIG.
  • the injection part 12 b of the injection nozzle 12 is brought close to the fusion pad 4.
  • the injection When the injection is discharged from the injection portion 12b of the injection nozzle 12 in this state, the injection is injected into the through hole 4a.
  • the fusion pad 4 is taken out from the culture vessel 3 and transferred to the carrying-out vessel and carried out from the isolator 5.
  • the culture vessel 3 may be transferred again from the isolator 5 to the incubator 6 and the culture may be continued to completely close the through-hole 4a.
  • FIG. 7 and 8 are diagrams for explaining a method for producing a cell aggregate structure as a second embodiment.
  • the pin 16 fixed to the pedestal 15 is a fusion pad.
  • 4 comprises a first pin group (16a) that holds the central part of the pin 4 and a second pin group (16b) shown in black that holds the outer peripheral edge part of the fusion pad 4.
  • the pins 16 b constituting the second pin group are arranged in a frame shape arranged on the outermost periphery and on the inner side in one row.
  • the cell aggregate 2 arranged on the outermost periphery thereof is held by the holding portion H formed by the pin 16b of the second pin group. It has become.
  • the pin 16 a constituting the first pin group is shorter than the pin 16 b constituting the second pin group, and the height of the holding portion H that holds the cell aggregate 2. Is set to a height near the tip of the pin 16a of the first pin group.
  • the pins of the first and second pin groups are the same as in the first embodiment.
  • the cell aggregate 2 is held in the holding portion H formed by 16a and 16b.
  • a culture process is performed, and when the cell aggregate 2 is fused to some extent to form the fusion pad 4 in the middle of the culture, the culture vessel 3 containing the cultured fusion pad 4 is transferred from the incubator 6 to the isolator 5. To do. Then, as shown in FIG.
  • the support plate 17 positioned at the lowered position is moved up and down to move the cultured fusion pad 4 to a height near the tip of the pin 16b of the second pin group, A detaching step for removing the pin 16a from the holding portion H of the first pin group is performed.
  • the fusion pad 4 is supported by the pin 16b of the second pin group, and the through hole 4a by the pin 16a of the first pin group is opened in the fusion pad 4.
  • the injection nozzle 12 performs an injection process of injecting an injection into the through hole 4a by the pin 16a of the first pin group of the fusion pad 4.
  • the fusion pad 4 is moved again from the isolator 5 to the incubator 6 to resume the culturing process, followed by culturing, whereby the through-hole 4a is filled with the cultured cells.
  • the fusion pad 4 may contract toward the center and bend in the process of closing the through hole 4a.
  • the outer peripheral edge of the fusion pad 4 is held by the pin 16b of the second pin group, so that the central portion of the fusion pad 4 is prevented from contracting and the thickness without bending is uniform. Can be obtained.
  • the culture container 3 is moved from the incubator 6 to the isolator 5 to perform the detachment process. Specifically, the support plate 17 is raised again from the lowered position to the raised position, and the fusion pad 4 is taken out from the holding portion H of the second pin group. Since the through-hole 4a by the pin 16b of the said 2nd pin group penetrated until then is formed in the outer periphery part of the fusion pad 4 obtained in this way, the fusion pad 4 of the fusion pad 4 is needed as needed.
  • the outer peripheral edge portion may be cut and removed, and only the central portion may be collected, or an injection process may be performed to inject an injection different from the through hole 4a by the pin 16a of the first pin group. It may be.
  • the through hole 4a formed by the pin 16a of the first pin group can be closed without being injected, and can be injected into the through hole 4a formed by the pin 16b of the second pin group.
  • the injection position of the injection can be designed by selectively arranging the first pin group and the second pin group.
  • FIG. 9 is a diagram for explaining a method for producing a cell aggregate structure as a third embodiment, in which the diameter of the cell aggregate 2 is smaller than the interval between the pins 16 at each diagonal position of the holding portion H. This corresponds to the case where the cell aggregate 2 cannot be held between the pin 16 and the pin 16.
  • FIG. 10 in order to make the produced fusion pad 4 thin, there is a variation in the case of using the smallest cell aggregate 2 or the size of the produced cell aggregate 2. It is assumed that the pin 16 and the pin 16 include a cell aggregate 2 that cannot be held and falls. Therefore, in the supply process of the present embodiment, as shown in FIG.
  • the cell aggregate 2 is accommodated with the space between the pins 16 as the holding portion H, and is positioned at the lowered position on the installation surface 15a of the pedestal 15.
  • Each cell aggregate 2 is held by being placed on the upper surface of the support plate 17.
  • the culture vessel 3 is transferred to the incubator 6 to start the culture process, and as shown in FIG. Incubate until mass 2 is fused.
  • the support plate 17 is raised to an intermediate position between the proximal end side and the distal end side of the pin 16, and separated from the installation surface 15a where the plurality of pins 16 are erected.
  • the cell aggregate 2 is held with the position being the holding portion H.
  • the fusion pad 4 having a predetermined size is obtained, the culture process shifts to the withdrawal process and the injection process.
  • FIG. 11 is a diagram for explaining a method for producing a cell aggregate structure as a fourth embodiment.
  • the tip of a pin 16 erected in the culture vessel 3 is formed with a sharp point.
  • the pin 16 is penetrated and held in the cell aggregate 2.
  • the cell assembly structure manufacturing apparatus 1 may be the same as that used in each of the above embodiments. However, when the cell aggregate 2 is penetrated by the pin 16 by the suction nozzle 10, The penetrating pin 16 is inserted into the suction portion 10b, and the lowering of the suction nozzle 10 is stopped at a predetermined position to hold the cell aggregate 2.
  • the cell aggregates 2 of the holding portions H adjacent to each other are fused in the culturing step, and the same fusion pad 4 as in the above embodiments can be obtained.
  • the support plate 17 can be moved to the upper position so that the cell aggregate 2 can be positioned above the pin 16.
  • the injection nozzle 12 the injection can be injected into each through hole 4a.
  • the through hole 4a is formed at the position where the pin 16 penetrates, and the injection nozzle 12 moves to the position of the pin 16 and injects.
  • FIG. 12 is a diagram for explaining a method for producing a cell aggregate structure according to the fifth embodiment.
  • the planar union pad 4 as the cell aggregate structure produced in the first to fourth embodiments is shown in FIG.
  • this embodiment a method for producing a three-dimensional aggregate structure of cells in which cell aggregates 2 are aligned in the Z direction will be described.
  • an apparatus having the same configuration as the cell assembly structure preparation apparatus 1 used in the first embodiment it is possible to use an apparatus having the same configuration as the cell assembly structure preparation apparatus 1 used in the first embodiment. The detailed description is omitted because it is possible and can be manufactured using substantially the same process.
  • the length of the pin 16 is set according to the desired height of the three-dimensional cell assembly, and is formed by four pins 16.
  • the holding portion H can hold a plurality of cell aggregates 2 in the Z direction.
  • the suction nozzle 10 supplies the cell aggregate 2 to the holding portion H formed by the pins 16 based on a preset three-dimensional arrangement of the cell aggregate 2. Specifically, first, the culture vessel support unit 9 sequentially moves the culture vessel 3 in the Y direction to supply the cell aggregate 2 to be arranged at the bottom, and then the cell aggregate held in the holding unit H What is necessary is just to supply the cell aggregate 2 to the upper part of 2 sequentially.
  • a gap g is formed below the cell aggregate 2 located at the lowermost stage, whereby the culture solution on the lower surface of the three-dimensional cell assembly structure is formed.
  • the culture solution is supplied, and a three-dimensional aggregate structure can be formed in the culture process.
  • the injection can be injected from the injection nozzle 12 into the through hole of the aggregate structure taken out from the holding portion H by performing the above-described detachment step and the above-described injection step.
  • the injection nozzle 12 may be inserted into a through-hole of the assembly structure to inject the injection into a required position in the vertical direction of the through-hole 4a.
  • the pin 16 that supports the cell aggregate 2 may be arranged with, for example, six pins 16 as long as the cell aggregate 2 can be supported by a plurality of pins 16. You may arrange
  • the size of the holding portion H formed by the pin 16, or the diameter of the cell aggregate 2 to be used depending on the thickness of the pin 16 provided in the culture vessel 3, the size of the holding portion H formed by the pin 16, or the diameter of the cell aggregate 2 to be used.
  • the diameter of the pin 16 shown in FIG. 13 is larger than the diameter of the pin 16 shown in the above embodiments, and the diameter of the cell aggregate 2 is larger than the interval between the two pins 16 at the diagonal positions.
  • maintenance part H does not contact is shown. Even in such a case, since the cell aggregate 2 is cultured and the adjacent cell aggregate 2 is fused in the culturing step, the fusion pad 4 as described above can be obtained, and the pin 16 is large. Since the diameter of the through-hole 4a formed in the fusion pad 4 is large, it is possible to inject a large amount of an injection into the through-hole 4a. Can also be defined.

Abstract

A method for producing a cell aggregate structure comprises: a supply step of holding a cell agglutinate clump 2 on a holding section H composed of multiple pins 16 that are provided so as to stand in a culture vessel 3; a culturing step of culturing the cell agglutinate clump 2 held on the holding section H to form a cell aggregate structure (an adhesion pad 4); a detachment step of detaching the adhesion pad 4 formed in the culturing step from the holding section H; and an injection step of injecting an injectant into the adhesion pad 4 detached in the detachment step through through-holes 4a that are formed by the pins 16 and open into the adhesion pad 4. It becomes possible to produce a cell aggregate structure having a desired shape and a desired dimension.

Description

細胞の集合構造体の作製方法および作製装置Method and apparatus for producing cell assembly structure
 本発明は細胞の集合構造体の作製方法および作製装置に関し、詳しくは培養液を収容した培養容器の内部に複数の細胞凝集塊を配置し、上記複数の細胞凝集塊が培養されて相互に融合した細胞の集合構造体を作製する細胞の集合構造体の作製方法および作製装置に関する。 The present invention relates to a method and apparatus for producing a cell aggregate structure, and more specifically, a plurality of cell aggregates are arranged inside a culture vessel containing a culture solution, and the plurality of cell aggregates are cultured and fused together. The present invention relates to a method and apparatus for manufacturing a cell aggregate structure.
 損傷を受けた生体機能を幹細胞などを用いて復元させる再生医療においては、細胞を高密度に培養した細胞シートが使用されている。この細胞シートは極めて薄いため、何枚かの細胞シートを重ね合わせる積層化培養細胞シートの製造方法が知られている(特許文献1)。
 またこのような細胞シートを重ね合わせる積層化培養細胞シートの製造方法において、積層する細胞シートと細胞シートとの間にハイドロゲル粒子を配置して、積層された部分の細胞に酸素や栄養等を行き渡らせ、より確実に細胞シートを製造する方法も知られている(特許文献2)。
 一方、予め細胞を略球状に培養した細胞凝集塊(スフェロイド)を相互に接触した状態に並べて浮遊培養を行い、細胞凝集塊同士が融合した50~300μmの厚みを有するシート状細胞凝集塊の作製方法も知られている(特許文献3)。
In regenerative medicine in which damaged biological functions are restored using stem cells or the like, cell sheets in which cells are cultured at high density are used. Since this cell sheet is extremely thin, a method for producing a laminated cultured cell sheet in which several cell sheets are superposed is known (Patent Document 1).
In addition, in the method for producing a laminated cultured cell sheet in which such cell sheets are superposed, hydrogel particles are arranged between the laminated cell sheets so that oxygen, nutrients, etc. are applied to the cells in the laminated part. A method for producing a cell sheet more reliably is also known (Patent Document 2).
On the other hand, cell aggregates (spheroids) in which cells have been cultured in a substantially spherical shape are arranged in contact with each other and subjected to suspension culture to produce a sheet-like cell aggregate having a thickness of 50 to 300 μm in which the cell aggregates are fused. A method is also known (Patent Document 3).
特許第4921353号公報Japanese Patent No. 4931353 特許第5862915号公報Japanese Patent No. 5862915 特許第5523830号公報Japanese Patent No. 5523830
 しかしながら、特許文献1、2のように細胞シートを積層化する場合、細胞シートは極めて薄いことから、取り扱いが難しく自動化することが困難であり、また特許文献3のように細胞凝集塊を浮遊培養してシート状細胞凝集塊を得ようとした場合、整列させた細胞凝集塊に粗密が生じて細胞凝集塊同士が不規則に融合するため、得られるシート状細胞凝集塊の形状が定まらず、厚さも不均一になるという問題があった。
 このような問題に鑑み、本発明は所要の形状および寸法を得ることが可能で、かつ機能性を付加することが可能であり、また自動化に対応した細胞の集合構造体の作製方法および作製装置を提供するものである。
However, when cell sheets are laminated as in Patent Documents 1 and 2, since the cell sheets are extremely thin, handling is difficult and it is difficult to automate, and cell aggregates are suspended and cultured as in Patent Document 3 When trying to obtain a sheet-like cell aggregate, the density of the aligned cell aggregate is generated and the cell aggregate aggregates irregularly, so the shape of the resulting sheet-like cell aggregate is not determined, There was a problem that the thickness became non-uniform.
In view of such a problem, the present invention can obtain a required shape and size, and can add functionality, and a method and apparatus for manufacturing a cell aggregate structure corresponding to automation Is to provide.
 すなわち請求項1の発明にかかる細胞の集合構造体の作製方法は、培養液を収容した培養容器の内部に複数の細胞凝集塊を配置し、上記複数の細胞凝集塊が培養されて相互に融合した細胞の集合構造体を作製する細胞の集合構造体の作製方法において、
 上記培養容器の内部に立設された複数のピンによって構成される保持部に細胞凝集塊を保持させる供給工程と、隣接する保持部に保持された細胞凝集塊を培養して上記集合構造体を形成する培養工程と、当該培養工程で形成された集合構造体を上記保持部から取り出す離脱工程と、当該離脱工程で取り出された集合構造体に開口する上記ピンによる貫通孔に注入物を注入する注入工程とを有することを特徴としている。
That is, in the method for producing a cell aggregate structure according to the invention of claim 1, a plurality of cell aggregates are arranged inside a culture vessel containing a culture solution, and the plurality of cell aggregates are cultured and fused to each other. In a method for producing a cell aggregate structure,
A supply step of holding a cell aggregate in a holding part constituted by a plurality of pins erected inside the culture vessel, and culturing the cell aggregate held in an adjacent holding part to form the aggregate structure A culturing step to be formed, a detaching step of taking out the aggregate structure formed in the culturing step from the holding portion, and injecting an injection into a through-hole by the pin opening in the aggregate structure taken out in the detaching step And an injection step.
 また請求項3の発明にかかる細胞の集合構造体の作製装置は、培養液を収容した培養容器の内部に複数の細胞凝集塊を配置し、上記複数の細胞凝集塊が培養されて相互に融合した細胞の集合構造体を作製する細胞の集合構造体の作製装置において、
 上記培養容器の内部に設けられ複数のピンを立設させた培養保持具と、上記培養保持具のピンによって構成される複数の保持部に細胞凝集塊を保持させる供給手段と、上記培養保持具に保持された細胞凝集塊が培養されて形成された集合構造体を上記培養保持具の上記保持部から取り出す離脱手段と、当該取り出された集合構造体に開口する上記ピンによる貫通孔に注入物を注入する注入手段とを備えることを特徴としている。
According to a third aspect of the present invention, there is provided an apparatus for producing a cell aggregate structure, in which a plurality of cell aggregates are arranged inside a culture vessel containing a culture solution, and the plurality of cell aggregates are cultured and fused together. In an apparatus for producing a cell aggregate structure,
A culture holder provided inside the culture vessel and provided with a plurality of pins, a supply means for holding a cell aggregate in a plurality of holding parts constituted by the pins of the culture holder, and the culture holder The detachment means for taking out the aggregate structure formed by culturing the cell agglomerates held in the cell from the holding part of the culture holder, and the injection into the through-hole by the pin opening to the extracted aggregate structure And injection means for injecting.
 上記請求項1および請求項3の発明によれば、上記培養保持具に設けた複数のピンとピンとの間を保持部として、複数の隣接する保持部で細胞凝集塊を保持するため、各細胞凝集塊は当該保持部で培養されることにより相互に融合し、所要の形状および寸法の細胞の集合構造体を作製することができ、これを自動化することができる。
 さらに、このようにして培養された細胞の集合構造体には、上記保持部を構成するピンによって貫通孔が形成されるため、当該貫通孔に注入物を注入することで、機能性を付加した細胞の集合構造体を作製することができる。
According to the first and third aspects of the present invention, each cell agglomeration is held by a plurality of adjacent holding portions with a plurality of pins provided in the culture holder as a holding portion. The clumps are fused with each other by being cultured in the holding part, and a cell aggregate structure having a required shape and size can be produced, and this can be automated.
Furthermore, since the through-hole is formed in the aggregate structure of the cells cultured in this way by the pins constituting the holding portion, functionality is added by injecting an injection into the through-hole. An aggregate structure of cells can be produced.
細胞の集合構造体の製造装置が設けられるアイソレータとインキュベータの正面図Front view of an isolator and an incubator provided with an apparatus for manufacturing a cell aggregate structure 細胞の集合構造体の製造装置の構成図Configuration diagram of cell assembly structure manufacturing equipment 収容容器および吸引ノズルについての断面図Cross-sectional view of the storage container and suction nozzle 培養容器の断面図Cross section of culture vessel 培養容器内に配置された細胞凝集塊についての平面図Plan view of cell clumps placed in the culture vessel 注入ノズルについての断面図であって、細胞の集合構造体の貫通孔に注入物を注入する注入工程を説明する図It is sectional drawing about an injection nozzle, Comprising: The figure explaining the injection | pouring process which inject | pours an injection material into the through-hole of the assembly structure of a cell 第2実施例における第1、第2ピン群を構成するピンの配置を説明する図The figure explaining arrangement | positioning of the pin which comprises the 1st, 2nd pin group in 2nd Example. 第2実施例における培養状態を示す図The figure which shows the culture state in 2nd Example 第3実施例における培養状態を示す図The figure which shows the culture state in 3rd Example 第3実施例において培養容器内に配置された細胞凝集塊についての平面図The top view about the cell agglomerate arrange | positioned in the culture container in 3rd Example 第4実施例における培養状態を示す図The figure which shows the culture state in 4th Example 第5実施例における培養状態を示す図The figure which shows the culture state in 5th Example ピンの太さと細胞凝集塊の大きさについて説明する図Diagram explaining pin thickness and cell clump size
 以下、図示実施例について説明すると、図1~図6は第1実施例にかかる細胞の集合構造体の作製装置1を説明するものであって、複数の細胞凝集塊2(スフェロイド:図3参照)を培養容器3の内部で配置し、上記細胞凝集塊2が培養されて相互に融合した細胞の集合構造体としての癒合パッド4(図4参照)を作製するものとなっている。
 上記細胞凝集塊2は、例えば特許第4517125号公報に開示される方法で作製することができる。すなわち、内面が非接着性の容器に細胞を播種して培養すると、細胞は足場を求めて互いに接着し合うことで凝集して細胞凝集塊2が形成され、これらがさらに融合することで外径寸法が500μm程度の略球状の細胞凝集塊2が形成される。
 より効率的には、ウエルプレートの非接着性のウエル(略半球状の収容部)で培養することにより容易に細胞凝集塊2を得ることができる。なお、細胞凝集塊2の作製方法はこれに限らず、旋回している培養液中に細胞懸濁液を入れる旋回培養法、試験管に細胞懸濁液を入れて遠心分離器で沈殿させる方法、あるいはアルギン酸ビーズを用いて培養する方法など公知の様々な方法で作製することができる。
 このように、細胞凝集塊2とは、細胞同士が集合し凝集化した100~700μm程度の外径寸法を有した略球状の細胞集合体を指し、これらの細胞凝集塊2を平面的または立体的に接触または接近させて配置すると、各細胞凝集塊2の細胞が増殖して隣接する細胞凝集塊2と融合し、平面的または立体的な細胞の集合構造体が得られるようになっている。
 本実施例で作製する癒合パッド4は、例えば骨、筋肉、内蔵、血管、皮膚などの組織や、臓器、器官を構成する体細胞やその前駆細胞、幹細胞などから作成され、骨や軟骨の欠損部を埋めたり、臓器や器官の表面に貼り付けて使用するものとなっている。
 また上記癒合パッド4は、複数の細胞凝集塊2を平面的に配置して融合させたものとなっており、厚さは用いる細胞凝集塊2の寸法に応じて100~700μm程度のものを作製することが可能で、平面的なサイズは整列させる細胞凝集塊2の個数によって調節可能となっている。
 このように作製される上記癒合パッド4は、細胞懸濁液を平面的に培養することで細胞単体をシート状に培養して得られる細胞シートとは異なるものである。
Hereinafter, the illustrated embodiment will be described. FIGS. 1 to 6 illustrate a cell aggregate structure manufacturing apparatus 1 according to the first embodiment, which includes a plurality of cell aggregates 2 (spheroids: see FIG. 3). ) Is placed inside the culture vessel 3, and the cell aggregate 2 is cultured to produce a fusion pad 4 (see FIG. 4) as an aggregate structure of cells fused together.
The cell aggregate 2 can be produced by, for example, a method disclosed in Japanese Patent No. 4517125. That is, when cells are seeded and cultured in a container whose inner surface is non-adhesive, the cells aggregate to form a cell aggregate 2 by adhering to each other in search of a scaffold, and these further fuse to form an outer diameter. A substantially spherical cell aggregate 2 having a dimension of about 500 μm is formed.
More efficiently, the cell aggregate 2 can be easily obtained by culturing in a non-adhesive well (substantially hemispherical accommodating portion) of the well plate. The method for producing the cell agglomerate 2 is not limited to this, and a swirl culture method in which the cell suspension is put in the swirling culture solution, or a method in which the cell suspension is put in a test tube and precipitated with a centrifuge Alternatively, it can be prepared by various known methods such as a culture method using alginate beads.
Thus, the cell aggregate 2 refers to a substantially spherical cell aggregate having an outer diameter of about 100 to 700 μm in which cells are aggregated and aggregated. These cell aggregates 2 are planar or three-dimensional. If the cells are placed in contact or close to each other, the cells of each cell aggregate 2 proliferate and fuse with the adjacent cell aggregate 2 to obtain a planar or three-dimensional aggregate structure of cells. .
The fusion pad 4 produced in the present embodiment is made from, for example, tissues such as bone, muscle, internal organs, blood vessels, skin, organs, somatic cells constituting the organs, precursor cells thereof, stem cells, etc., and bone or cartilage defects. It is intended to be used by filling the part or pasting it on the surface of an organ or organ.
Further, the above-mentioned fusion pad 4 is obtained by arranging a plurality of cell aggregates 2 in a plane and fusing them, and a thickness of about 100 to 700 μm is produced according to the size of the cell aggregates 2 to be used. The planar size can be adjusted by the number of cell aggregates 2 to be aligned.
The fusion pad 4 thus produced is different from a cell sheet obtained by culturing a cell suspension in a planar form by culturing a cell suspension in a planar manner.
 本実施例の細胞の集合構造体の作製装置1は、図1に示す内部が無菌状態に維持されたアイソレータ5と、当該アイソレータ5に接続可能に設けられたインキュベータ6との内部に設けられている。また、アイソレータ5には、搬入物を除染するためのパスボックス5aが設けられている。
 図2は上記アイソレータ5の内部に設けられた構成を示し、細胞凝集塊2を収容する収容容器7を支持する収容容器支持部8と、癒合パッド4の培養される培養容器3を支持する培養容器支持部9と、上記細胞凝集塊2を保持する複数の吸引ノズル10と、上記吸引ノズル10を上記収容容器7および培養容器3に対して相対的に移動させる吸引ノズル移動手段11と、培養された癒合パッド4に注入物を注入する注入手段としての注入ノズル12と、上記注入ノズル12を上記培養容器3に対して相対的に移動させる注入ノズル移動手段13とを備えている。
 なお、以下の説明において、図2における図示左右方向をX方向、前後方向をY方向、上下方向をZ方向とし、図5では図示左右方向をX方向、上下方向をY方向とする。
The cell assembly structure manufacturing apparatus 1 of the present embodiment is provided inside an isolator 5 in which the interior shown in FIG. 1 is maintained in a sterile state and an incubator 6 provided so as to be connectable to the isolator 5. Yes. In addition, the isolator 5 is provided with a pass box 5a for decontaminating the incoming material.
FIG. 2 shows a configuration provided inside the isolator 5, and a container supporting unit 8 that supports the container 7 that stores the cell aggregate 2 and a culture that supports the culture container 3 in which the fusion pad 4 is cultured. A container support 9, a plurality of suction nozzles 10 for holding the cell aggregate 2, suction nozzle moving means 11 for moving the suction nozzle 10 relative to the storage container 7 and the culture container 3, and culture An injection nozzle 12 as injection means for injecting an injection into the fusion pad 4 and an injection nozzle moving means 13 for moving the injection nozzle 12 relative to the culture vessel 3 are provided.
In the following description, the horizontal direction shown in FIG. 2 is the X direction, the front-rear direction is the Y direction, the vertical direction is the Z direction, and in FIG. 5, the horizontal direction is the X direction and the vertical direction is the Y direction.
 上記アイソレータ5は内部が無菌環境に維持され、また無菌エア供給手段によって上方から下方へと向かう無菌エアによる一方向流が形成されるようになっている。
 またアイソレータ5の正面には作業者が装着可能なグローブ5bが設けられており、各種の作業を行うことが可能となっている。なお、アイソレータ5の内部にロボットや所要の構成を有した移送手段を設けて、これらの作業を自動的に行うようにすることもできる。
 次に、上記インキュベータ6は、内部が無菌環境に維持されるとともに、癒合パッド4の培養に適した所定の温度および湿度に維持され、細胞凝集塊2が融合して癒合パッド4へと形成される間、上記インキュベータ6を上記アイソレータ5より分離して、当該アイソレータ5より離れた場所に載置することが可能となっている。
 そのため、上記アイソレータ5とインキュベータ6とは接続手段5cによって接続されており、例えば特許第4656485号公報に記載されるような、インキュベータ6とアイソレータ5とを無菌状態を維持したまま接離させる接続手段を使用することができる。
The interior of the isolator 5 is maintained in a sterile environment, and a one-way flow is generated by aseptic air from above to below by the sterile air supply means.
In addition, a glove 5b that can be worn by an operator is provided in front of the isolator 5, so that various operations can be performed. It is also possible to provide a robot or a transfer means having a required configuration inside the isolator 5 so that these operations are automatically performed.
Next, the inside of the incubator 6 is maintained in a sterile environment and is maintained at a predetermined temperature and humidity suitable for culturing the fusion pad 4, and the cell aggregate 2 is fused to form the fusion pad 4. During this time, the incubator 6 can be separated from the isolator 5 and placed at a location away from the isolator 5.
Therefore, the isolator 5 and the incubator 6 are connected by the connecting means 5c. For example, as described in Japanese Patent No. 4656485, the connecting means for contacting and separating the incubator 6 and the isolator 5 while maintaining the sterility. Can be used.
 図3は上記収容容器7の断面図を示し、上述したウエルプレートを使用することができる。収容容器7は平面視において縦横に複数の収容凹部7aを備え、各収容凹部7aの内部には培養液とともに略球状の細胞凝集塊2が一個ずつ収容されている。
 上記収容容器7の収容凹部7aは、平面視におけるX方向およびY方向にそれぞれ所定個数ずつ整列しており、本実施例では培養容器3において作製する癒合パッド4を構成する細胞凝集塊2のX方向およびY方向の個数と同数、すなわちX方向に5個、Y方向に5個それぞれ設けられている。
FIG. 3 shows a cross-sectional view of the container 7, and the well plate described above can be used. The storage container 7 includes a plurality of storage recesses 7a vertically and horizontally in a plan view, and each of the storage recesses 7a stores a substantially spherical cell aggregate 2 together with a culture solution one by one.
The storage recesses 7a of the storage container 7 are arranged in a predetermined number in the X direction and the Y direction in plan view. In this embodiment, the X of the cell aggregate 2 constituting the fusion pad 4 produced in the culture container 3 is used. The number is the same as the number in the direction and the Y direction, that is, five in the X direction and five in the Y direction.
 上記収容容器7を支持する収容容器支持部8は、位置決め片8bによってその上面で上記収容容器7を位置決めするとともに、上記吸引ノズル移動手段11を構成するY方向テーブル8aによって構成されている。
 後述するように、本実施例の吸引ノズル10はX方向に5個設けられ、またX方向およびZ方向にのみ移動可能となっていることから、上記Y方向テーブル8aが収容容器7をY方向に移動させることで、吸引ノズル10と収容容器7とをXYZの各方向で相対的に移動させることができる。
 具体的に説明すると、最初に上記Y方向テーブル8aが収容容器7の1列目の収容凹部7aを吸引ノズル10の下方に位置させて、当該一列目の収容凹部7aから吸引ノズル10が細胞凝集塊2を吸着保持すると、Y方向テーブル8aが1列分だけY方向に収容容器7を移動させて、2列目の収容凹部7aを吸引ノズル10の下方に位置させるようになっている。
The storage container support 8 that supports the storage container 7 is configured by a Y-direction table 8a that constitutes the suction nozzle moving means 11 while positioning the storage container 7 on the upper surface thereof by a positioning piece 8b.
As will be described later, five suction nozzles 10 of the present embodiment are provided in the X direction, and are movable only in the X direction and the Z direction. Therefore, the Y direction table 8a moves the container 7 in the Y direction. The suction nozzle 10 and the container 7 can be relatively moved in each direction of XYZ.
Specifically, the Y-direction table 8a first positions the first row of storage recesses 7a of the storage container 7 below the suction nozzle 10, and the suction nozzle 10 aggregates cells from the first row of storage recesses 7a. When the lump 2 is sucked and held, the Y-direction table 8a moves the storage container 7 in the Y direction by one row, and the second row of storage recesses 7a is positioned below the suction nozzle 10.
 図4に示すように、培養容器3は有底箱状を有しており、内部には所定の深さで培養液が収容されるとともに、底面に設置された底面プレート14と、当該底面プレート14に設置された台座15および当該台座15に立設された複数のピン16から構成される培養保持具と、上記ピン16に沿って上下に移動する支持部材としての支持プレート17とが設けられている。
 上記底面プレート14は培養容器3の底面と略同形を有しており、底面プレート14が培養容器3の内部で移動しないように位置決めされている。また上記台座15は直方体形状を有しており、底面プレート14の上面に形成された凹部14aに嵌合して位置決めされるようになっている。
As shown in FIG. 4, the culture vessel 3 has a bottomed box shape, in which a culture solution is accommodated at a predetermined depth, and a bottom plate 14 installed on the bottom surface, and the bottom plate 14 and a culture holder comprising a plurality of pins 16 erected on the pedestal 15 and a support plate 17 as a support member that moves up and down along the pins 16 are provided. ing.
The bottom plate 14 has substantially the same shape as the bottom surface of the culture vessel 3 and is positioned so that the bottom plate 14 does not move inside the culture vessel 3. The pedestal 15 has a rectangular parallelepiped shape, and is positioned by being fitted into a recess 14 a formed on the upper surface of the bottom plate 14.
 上記ピン16は上記台座15の上面に形成された設置面15aにそれぞれZ方向を向くように規則的に立設されている。
 図5は上記台座15に設けられたピン16と、当該ピン16によって保持される細胞凝集塊2についての平面図を示し、本実施例ではX方向およびY方向にそれぞれ5個の細胞凝集塊2を相互に接触した状態で平面的に整列させるようになっている。
 上記ピン16は、各細胞凝集塊2の周囲に位置するように設けられており、本実施例では4本のピン16によって細胞凝集塊2を保持する保持部Hを構成している。より具体的には、平面視において4本のピン16が四隅に位置する略正方形の区画を上記保持部Hとしている。
 本実施例では、上記保持部Hを構成する4本のピン16のうち、各対角位置の2本のピン16の間隔は、保持する細胞凝集塊2の直径よりも短くなるように配置されている。換言すると、細胞凝集塊2を作製する際に、各対角位置の2本のピン16の間隔よりも直径が大きくなるようにしている。
 このように構成された保持部Hに細胞凝集塊2を保持すると、複数のピン16とピン16との間で細胞凝集塊2を挟持することができ、図4(a)のように細胞凝集塊2を上記ピン16の先端と根元との間の上下中間部分に位置させることが可能となる。
 換言すると、上記保持部Hを上記複数のピン16を立設した設置面15aから離隔した位置に設定することができ、当該保持部Hに保持された細胞凝集塊2と設置面15aとの間に、培養液が流通可能な隙間gを形成することができる。
 またピン16の直径にもよるが、各対角位置の2本のピン16の間隔を細胞凝集塊2の直径よりも短くすることで、各保持部Hの細胞凝集塊2同士を相互に接触させた状態で培養することができるようになっている。
The pins 16 are regularly erected on an installation surface 15 a formed on the upper surface of the pedestal 15 so as to face the Z direction.
FIG. 5 shows a plan view of the pin 16 provided on the pedestal 15 and the cell aggregate 2 held by the pin 16, and in this embodiment, five cell aggregates 2 in the X direction and Y direction, respectively. Are arranged in a plane in contact with each other.
The pin 16 is provided so as to be located around each cell aggregate 2, and in this embodiment, the holding part H that holds the cell aggregate 2 is configured by four pins 16. More specifically, a substantially square section where the four pins 16 are located at the four corners in plan view is the holding portion H.
In the present embodiment, among the four pins 16 constituting the holding portion H, the interval between the two pins 16 at each diagonal position is arranged to be shorter than the diameter of the cell aggregate 2 to be held. ing. In other words, when the cell aggregate 2 is produced, the diameter is made larger than the interval between the two pins 16 at each diagonal position.
When the cell aggregate 2 is held in the holding portion H configured as described above, the cell aggregate 2 can be held between the plurality of pins 16 and the pins 16, and the cell aggregate 2 as shown in FIG. The lump 2 can be positioned at the upper and lower intermediate portion between the tip and the root of the pin 16.
In other words, the holding portion H can be set at a position separated from the installation surface 15a where the plurality of pins 16 are erected, and between the cell aggregate 2 held by the holding portion H and the installation surface 15a. In addition, a gap g through which the culture solution can be circulated can be formed.
Further, although depending on the diameter of the pins 16, the cell aggregates 2 of the holding portions H are brought into contact with each other by making the interval between the two pins 16 at the diagonal positions shorter than the diameter of the cell aggregate 2. It can be cultured in a state of being allowed to stand.
 上記底面プレート14には、上記台座15を挟んで対向した位置に設けられるとともに、Z方向に向けて立設されて上記支持プレート17を上下に貫通する2本の棒状のガイド部材18が設けられ、上記支持プレート17には上記ピン16が貫通する貫通孔17aが穿設されている。
 上記構成により、上記支持プレート17は上記ピン16およびガイド部材18に沿ってZ方向に昇降可能に設けられるとともに、通常は自重により上記台座15の設置面15aに載置されるピン16の基端側となる下降位置に位置している。
 図4(a)に示す支持プレート17が下降位置に位置した際、上記ピン16の上下中間部分に保持された細胞凝集塊2と上記台座15の設置面15aとの間には、培養液が流通可能な隙間gが形成されるようになっている。
 一方、図4(b)に示すように、支持プレート17を上昇させると、支持プレート17は上記ピン16とピン16との間に保持された細胞凝集塊2を下方から支持することができ、上記支持プレート17がピン16の先端側となる上昇位置まで位置することで、細胞凝集塊2が培養された癒合パッド4を上記ピン16の間の保持部Hから取り出すことができるようになっている。
 上記支持プレート17の上昇は、グローブ5bを装着した作業者によって行える他、ロボット等によって行うことも可能である。その際、図示しないが上記支持プレート17の上面に上記培養液の液面より上方に突出する把持部材を設けることで、培養液に触れずに支持プレート17を上昇させることが可能となる。
The bottom plate 14 is provided with two rod-shaped guide members 18 which are provided at positions opposed to each other with the pedestal 15 interposed therebetween and which are erected in the Z direction and penetrate the support plate 17 up and down. The support plate 17 has a through hole 17a through which the pin 16 passes.
With the above configuration, the support plate 17 is provided so as to be movable up and down in the Z direction along the pin 16 and the guide member 18, and usually the base end of the pin 16 placed on the installation surface 15 a of the pedestal 15 by its own weight. It is located at the lowered position.
When the support plate 17 shown in FIG. 4 (a) is positioned at the lowered position, the culture solution is interposed between the cell aggregate 2 held on the upper and lower intermediate portions of the pin 16 and the installation surface 15a of the pedestal 15. The gap | interval g which can be distribute | circulated is formed.
On the other hand, as shown in FIG. 4B, when the support plate 17 is raised, the support plate 17 can support the cell aggregate 2 held between the pins 16 and 16 from below, Since the support plate 17 is positioned up to the ascending position on the tip side of the pin 16, the fusion pad 4 on which the cell aggregate 2 is cultured can be taken out from the holding portion H between the pins 16. Yes.
The support plate 17 can be raised by an operator wearing the globe 5b, or by a robot or the like. At this time, although not shown, by providing a grip member protruding above the surface of the culture solution on the upper surface of the support plate 17, the support plate 17 can be raised without touching the culture solution.
 図2に示すように、培養容器支持部9は上記吸引ノズル移動手段11を構成するY方向テーブル9aによって構成され、上記収容容器支持部8を構成するY方向テーブル8aと同様、吸引ノズル10に吸着保持された細胞凝集塊2が上記ピン16によって構成された保持部Hに供給されるたびに、培養容器3ごとピン16間に設定された保持部Hを上記Y方向に一列ずつ移動させるものとなっている。 As shown in FIG. 2, the culture vessel support portion 9 is constituted by a Y-direction table 9 a that constitutes the suction nozzle moving means 11, and is similar to the Y-direction table 8 a that constitutes the storage vessel support portion 8. Each time the adsorbed and held cell aggregate 2 is supplied to the holding part H constituted by the pin 16, the holding part H set between the pins 16 together with the culture vessel 3 is moved in a row in the Y direction. It has become.
 次に、上記吸引ノズル10について説明すると、図3に示すように図示しない負圧発生手段に接続された本体部10aと、当該本体部10aの下端部に設けられた管状の吸着部10bとを備えている。
 上記吸着部10bの内径は上記細胞凝集塊2より小径となっており、上記収容容器7の収容凹部7aにおいて吸着部10bの先端に細胞凝集塊2を吸着保持した際に、細胞凝集塊2が当該吸着部10bの内部に吸い込まれないようになっている。
 また培養容器3においては、上記吸着部10bの中心位置をピン16とピン16との間に形成した保持部Hの略中央に位置させ、かつ細胞凝集塊2を上記ピン16の上下中間位置に位置した状態で上記負圧発生手段による負圧を解消する。
 なお細胞凝集塊2を吸着保持する吸引ノズル10に代えて、グリッパなどによって細胞凝集塊2を保持する等の構成を有したものを用いて細胞凝集塊2を保持するようにしてもよい。
Next, the suction nozzle 10 will be described. As shown in FIG. 3, a main body portion 10a connected to a negative pressure generating means (not shown) and a tubular suction portion 10b provided at the lower end portion of the main body portion 10a. I have.
The inner diameter of the adsorbing portion 10b is smaller than that of the cell aggregate 2 and when the cell aggregate 2 is adsorbed and held at the tip of the adsorbing portion 10b in the accommodating recess 7a of the accommodating container 7, the cell aggregate 2 The suction portion 10b is not sucked into the interior.
In the culture vessel 3, the center position of the adsorbing portion 10 b is positioned at the approximate center of the holding portion H formed between the pin 16 and the pin 16, and the cell aggregate 2 is positioned at the upper and lower intermediate positions of the pin 16. The negative pressure by the negative pressure generating means is eliminated in the positioned state.
Instead of the suction nozzle 10 for adsorbing and holding the cell aggregate 2, the cell aggregate 2 may be held using a structure having a configuration such as holding the cell aggregate 2 with a gripper or the like.
 また上記吸引ノズル10を移動させる吸引ノズル移動手段11は、上記収容容器支持部8および培養容器支持部9にかけてX方向に設けられたX方向レール21と、当該X方向レール21に沿って吸引ノズル10をX方向に移動させるX方向移動手段22と、当該X方向移動手段22に設けられてZ方向に吸引ノズル10を昇降させるZ方向移動手段23と、上記収容容器支持部8および培養容器支持部9における上記Y方向テーブル8a、9aとによって構成されている。なお、吸引ノズル移動手段11としては、Y方向テーブル8a、9aに代えて、上記X方向レール21をY方向に移動させる構成を有したものであってもよい。このような構成とすることで、上記吸引ノズル10や注入ノズル12、後述するカメラ25をX-Y方向に移動させることができる。 The suction nozzle moving means 11 for moving the suction nozzle 10 includes an X-direction rail 21 provided in the X direction over the storage container support 8 and the culture container support 9, and a suction nozzle along the X-direction rail 21. X direction moving means 22 for moving 10 in the X direction, Z direction moving means 23 provided in the X direction moving means 22 for raising and lowering the suction nozzle 10 in the Z direction, the container holding unit 8 and the culture vessel support The unit 9 is composed of the Y-direction tables 8a and 9a. The suction nozzle moving means 11 may be configured to move the X-direction rail 21 in the Y direction instead of the Y-direction tables 8a and 9a. With such a configuration, the suction nozzle 10, the injection nozzle 12, and the camera 25 described later can be moved in the XY direction.
 また本実施例の吸引ノズル10はX方向に5個整列して設けられ、これら吸引ノズル10は間隔変更手段24によってX方向にその間隔が変更されるようになっている。
 具体的には、上記吸引ノズル10が収容容器支持部8の上方に位置した際には、間隔変更手段24は上記収容容器7におけるX方向に整列した収容凹部7aと同じ間隔に上記吸引ノズル10の間隔を変更する。
 一方、吸引ノズル10が培養容器支持部9の上方に位置した際には、間隔変更手段24は上記培養容器3の内部のピン16とピン16との間に形成された保持部Hにおける、X方向の間隔と同じ間隔に吸引ノズル10の間隔を変更する。
 なお、吸引ノズル10についてはY方向に複数列設けることも可能であり、また収容容器支持部8の収容凹部7aの間隔と、上記ピン16とピン16との間に形成された保持部Hの間隔とが同じ場合には、上記間隔変更手段24を省略することができる。
 また例えば上記保持部Hの間隔が狭い場合には、上記吸引ノズル10によって一つおきの保持部Hに細胞凝集塊2を保持させることも可能であり、その場合、最初に奇数番目の保持部Hに細胞凝集塊2を保持させ、その後偶数番目の保持部Hに細胞凝集塊2を保持させるようにすればよい。
 なお、吸引ノズル10は少なくとも1本備えられていれば良く、また、細胞凝集塊2の供給手段としては、本実施例のように細胞凝集塊2を移載する構成の他、多数の細胞凝集塊2を収容した容器から1個ずつ繰り出すような構成であっても良い。
Further, five suction nozzles 10 according to the present embodiment are arranged in the X direction, and the intervals of these suction nozzles 10 are changed in the X direction by the interval changing means 24.
Specifically, when the suction nozzle 10 is positioned above the storage container support 8, the interval changing means 24 is arranged at the same interval as the storage recesses 7 a aligned in the X direction in the storage container 7. Change the interval.
On the other hand, when the suction nozzle 10 is positioned above the culture vessel support 9, the interval changing means 24 is set to X in the holding portion H formed between the pins 16 inside the culture vessel 3. The interval of the suction nozzle 10 is changed to the same interval as the direction interval.
The suction nozzles 10 can be provided in a plurality of rows in the Y direction, and the interval between the accommodation recesses 7a of the accommodation container support 8 and the holding portion H formed between the pins 16 and 16 can be provided. When the interval is the same, the interval changing means 24 can be omitted.
Further, for example, when the interval between the holding portions H is narrow, it is possible to hold the cell aggregate 2 in every other holding portion H by the suction nozzle 10, and in this case, the odd-numbered holding portions are initially set. The cell aggregate 2 may be held by H, and then the cell aggregate 2 may be held by the even-numbered holding part H.
In addition, it is sufficient that at least one suction nozzle 10 is provided, and as a means for supplying the cell aggregate 2, in addition to the configuration for transferring the cell aggregate 2 as in this embodiment, a number of cell aggregates are provided. The configuration may be such that one by one is delivered from the container containing the lump 2.
 図6に示すように、上記注入ノズル12は、図示しない注入物供給手段に接続された本体部12aと、当該本体部12aの下端部に設けられた管状の注入部12bとを備え、後述するように培養された癒合パッド4に開口する貫通孔4aに注入物を注入するものとなっている。
 上記注入物供給手段からは、注入物として細胞の培養を促進させる栄養成分や、癒合パッド4を患者に移植した後の生着や成長、周辺組織の再生を促す成長因子や増殖因子、血管の新生を促す細胞懸濁液、移植後の生体に作用する薬物等が、液体、ジェル、ゲル、粒子、顆粒等の状態で供給され、これらは上記注入部12bの先端から排出されて上記癒合パッド4の貫通孔4aに注入されるようになっている。なお、注入は貫通孔4aの上方で行ってもよいし、注入ノズル12を貫通孔4aに挿入して行うこともできる。
 このように貫通孔4aに注入することで、注入物を癒合パッド4の内部に埋め込むことができ、注入物を単に癒合パッド4の表面に滴下する場合に比べて多量の注入物を当該癒合パッド4の内部に浸透させることができる。
 そして上記注入物が注入された癒合パッド4については、引き続き培養して上記貫通孔4aを塞いでもよいし、そのまま回収して移植に用いることもできる。
As shown in FIG. 6, the injection nozzle 12 includes a main body portion 12a connected to an injection supply means (not shown) and a tubular injection portion 12b provided at the lower end of the main body portion 12a. Thus, the injection is injected into the through-hole 4a opened in the fusion pad 4 thus cultured.
From the above-mentioned injection supply means, nutritional components that promote cell culture as injections, engraftment and growth after transplantation of the fusion pad 4 to a patient, growth factors and growth factors that promote regeneration of surrounding tissues, blood vessel A cell suspension that promotes neoplasia, a drug that acts on the living body after transplantation, and the like are supplied in the form of a liquid, gel, gel, particle, granule, and the like. 4 through holes 4a. The injection may be performed above the through hole 4a, or may be performed by inserting the injection nozzle 12 into the through hole 4a.
By injecting into the through-hole 4a in this way, the injection can be embedded in the fusion pad 4, and a larger amount of the injection than in the case where the injection is simply dropped on the surface of the fusion pad 4 4 can penetrate.
And about the fusion pad 4 in which the said injection was inject | poured, it may culture | cultivate continuously and may block the said through-hole 4a, or it can collect | recover as it is and can also be used for a transplant.
 図2に示すように、注入ノズル12はX方向に4個整列して設けられており、具体的には上記培養容器3の内部でX方向に整列したピン16の間隔と同じ間隔、すなわち癒合パッド4の貫通孔4aと同じ間隔となるように設けられている。
 上記注入ノズル12を移動させる注入ノズル移動手段13は、上記吸引ノズル移動手段11と共通して用いられるX方向レール21と、当該X方向レール21に沿って移動する左右移動手段25と、当該左右移動手段25に設けられて注入ノズル12をZ方向に昇降させる上下移動手段26と、上記培養容器支持部9における上記Y方向テーブル9aとによって構成されている。
 なお、注入ノズル12は少なくとも1本備えられていれば良く、また、注入ノズル移動手段13は、Y方向テーブル9aを備えず当該注入ノズル12をX方向およびY方向に移動させるよう構成することもできる。
 また複数の注入ノズル12を備えて、それらを個別に移動させるよう構成することにより、異なる注入物を注入できるようにすることも可能である。
As shown in FIG. 2, four injection nozzles 12 are arranged in the X direction, specifically, the same interval as the interval of the pins 16 aligned in the X direction inside the culture vessel 3, that is, fusion. The pads 4 are provided so as to have the same spacing as the through holes 4 a of the pads 4.
The injection nozzle moving means 13 for moving the injection nozzle 12 includes an X-direction rail 21 that is used in common with the suction nozzle movement means 11, a left-right movement means 25 that moves along the X-direction rail 21, The moving unit 25 includes a vertical moving unit 26 that moves the injection nozzle 12 up and down in the Z direction, and the Y direction table 9 a in the culture vessel support 9.
It is sufficient that at least one injection nozzle 12 is provided, and the injection nozzle moving means 13 may be configured not to include the Y-direction table 9a but to move the injection nozzle 12 in the X direction and the Y direction. it can.
It is also possible to inject different injections by providing a plurality of injection nozzles 12 and moving them individually.
 上記X方向レール21には、X方向に移動する横移動手段27にカメラ28が設けられており、当該カメラ28を培養容器支持部9の上方まで移動させて培養容器3の内部を撮影するようになっている。
 上記吸引ノズル10によって細胞凝集塊2を保持部Hに保持させる際には、上記カメラ28が撮影した画像により、上記全ての保持部Hに細胞凝集塊2が保持されているか否かを確認し、必要に応じて細胞凝集塊2の保持されていない保持部Hに対して細胞凝集塊2を供給するように指示することができる。
 さらに、上記注入ノズル12によって注入物を癒合パッド4に注入する際には、上記カメラ28が撮影した画像により、癒合パッド4の貫通孔4aの位置が認識されるようになっている。
 またカメラ28は、上記吸引ノズル移動手段11が吸引ノズル10を培養容器支持部9の上方に位置させる際、ならびに注入ノズル移動手段13が注入ノズル12を培養容器支持部9の上方に位置させる際には、これらとの接触を避けるために培養容器支持部9の上方から退避するようになっている。
The X-direction rail 21 is provided with a camera 28 in a lateral movement means 27 that moves in the X direction, and the camera 28 is moved to above the culture vessel support 9 to photograph the inside of the culture vessel 3. It has become.
When the cell aggregate 2 is held in the holding part H by the suction nozzle 10, it is confirmed from the images taken by the camera 28 whether or not the cell aggregate 2 is held in all the holding parts H. If necessary, it can be instructed to supply the cell aggregate 2 to the holding part H where the cell aggregate 2 is not held.
Furthermore, when the injection is injected into the fusion pad 4 by the injection nozzle 12, the position of the through hole 4a of the fusion pad 4 is recognized from the image taken by the camera 28.
The camera 28 is also used when the suction nozzle moving means 11 positions the suction nozzle 10 above the culture vessel support 9 and when the injection nozzle movement means 13 positions the injection nozzle 12 above the culture vessel support 9. In order to avoid contact with these, they are retracted from above the culture vessel support 9.
 以下において、上記構成を有する細胞の集合構造体の作製装置1を用いた癒合パッド4の作製方法を説明する。
 最初に、上記パスボックス5aを介して上記細胞凝集塊2が収容された収容容器7や培養容器3を上記アイソレータ5内に搬入したり、培養容器3に所定量の培養液を供給する準備工程を行う。
 また培養容器3には上記台座15および複数のピン16からなる培養保持具が設置され、また上記支持プレート17は自重により上記台座15の設置面15aに接触した下降位置に位置している。
 さらに準備工程において、アイソレータ5の内部に上記収容容器7や培養容器3を複数搬入すれば、複数の培養容器3を用いて複数の癒合パッド4を連続して作製することが可能となる。
Hereinafter, a method for producing the fusion pad 4 using the cell assembly structure producing apparatus 1 having the above-described configuration will be described.
First, a preparation step of carrying the container 7 or the culture container 3 containing the cell aggregate 2 through the pass box 5a into the isolator 5 or supplying a predetermined amount of culture solution to the culture container 3 I do.
The culture vessel 3 is provided with a culture holder comprising the pedestal 15 and a plurality of pins 16, and the support plate 17 is located at a lowered position in contact with the installation surface 15 a of the pedestal 15 by its own weight.
Furthermore, in the preparation step, if a plurality of the storage containers 7 and culture containers 3 are carried into the isolator 5, a plurality of fusion pads 4 can be continuously produced using the plurality of culture containers 3.
 上記準備工程が完了したら、続いて上記吸引ノズル10により上記収容容器7から上記培養容器3へと細胞凝集塊2を移動させて、培養容器3の上記ピン16によって設定された保持部Hに細胞凝集塊2を供給する供給工程を行う。
 上記吸引ノズル移動手段11が吸引ノズル10を移動させ、また間隔変更手段24が吸引ノズル10の間隔を変更して、上記収容容器支持部8において収容容器7の収容凹部7aから細胞凝集塊2を吸着保持する。
 続いて、吸引ノズル移動手段11が吸引ノズル10を培養容器支持部9へと移動させ、また間隔変更手段24が上記ピン16とピン16との間に形成された保持部Hの間隔に合わせて吸引ノズル10の間隔を変更し、吸引ノズル10を下降させる。
 すると、吸引ノズル10に保持された各細胞凝集塊2は4本のピン16の間に形成された保持部Hに挿入され、細胞凝集塊2の下方に隙間gが形成されるよう、上記ピン16の上下中間位置に細胞凝集塊2が保持される。
 このようにして全ての保持部Hに細胞凝集塊2が保持されると、その後上記カメラ28が培養容器支持部9の上方に移動して培養容器3内の細胞凝集塊2を撮影し、細胞凝集塊2が所要の保持部Hに配置されているか否かを確認する。
When the preparation step is completed, the cell aggregate 2 is subsequently moved from the container 7 to the culture vessel 3 by the suction nozzle 10, and the cells are placed in the holding part H set by the pins 16 of the culture vessel 3. A supplying step for supplying the aggregate 2 is performed.
The suction nozzle moving means 11 moves the suction nozzle 10, and the interval changing means 24 changes the interval of the suction nozzle 10, so that the cell aggregate 2 is removed from the accommodating recess 7 a of the accommodating container 7 in the accommodating container support 8. Hold by adsorption.
Subsequently, the suction nozzle moving means 11 moves the suction nozzle 10 to the culture vessel support portion 9, and the interval changing means 24 is adjusted to the interval of the holding portion H formed between the pins 16 and 16. The interval of the suction nozzle 10 is changed, and the suction nozzle 10 is lowered.
Then, each cell aggregate 2 held by the suction nozzle 10 is inserted into the holding portion H formed between the four pins 16, and the pin g is formed so that a gap g is formed below the cell aggregate 2. The cell aggregate 2 is held at 16 upper and lower intermediate positions.
When the cell aggregates 2 are held in all the holding parts H in this way, the camera 28 then moves above the culture container support part 9 to photograph the cell aggregates 2 in the culture container 3, and the cells It is confirmed whether or not the agglomerate 2 is arranged in the required holding part H.
 このようにして培養容器3内に細胞凝集塊2が配置されると、ロボットもしくは作業者の手作業により、上記培養容器3はインキュベータ6に移送され、当該培養容器3内の細胞凝集塊2を培養する培養工程が行われる。
 まず上記培養容器3をインキュベータ6に移送したら、インキュベータ6を上記アイソレータ5より分離して、アイソレータ5より離隔した位置に載置し、内部を所定の温度、湿度に維持するとともに、所定の炭酸ガスや酸素の濃度を維持する。
 培養容器3内において、細胞凝集塊2が培養されると隣接する保持部Hの細胞凝集塊2が相互に融合し、これにより細胞凝集塊2が平面的に配置された形状を維持した細胞の集合構造体としての癒合パッド4を得ることができる。
 つまり、各細胞凝集塊2は上記ピン16によって移動が規制されているため、形成される癒合パッド4の寸法を、はじめに細胞凝集塊2を配置した際の大きさと略同一にすることができ、細胞凝集塊2を配置した通りに任意の形状の癒合パッド4を作製することが可能となる。
 これは、細胞凝集塊2が接触している上記ピン16の周囲に密着するように増殖または移動し、隣接する細胞凝集塊2同士の間に形成される間隙を埋めるためであり、ピン16を介さず細胞凝集塊2を平面的に配置して培養する場合のように、全体的な寸法はほとんど縮むことがない。
 またその際、上記細胞凝集塊2の下方には上記隙間gが形成されていることから、癒合パッド4と台座15の設置面15aとの間に培養液が供給され、癒合パッド4の裏面側についても効率的に培養することができる。
 つまり、細胞凝集塊2を上記設置面15aに載置させて癒合パッド4を作製する場合、中央に位置する細胞凝集塊2の下面側には十分に培養液が行き渡らないという問題があったが、細胞凝集塊2を下方に隙間gを形成した状態で保持することにより、当該部分に位置する細胞も良好に培養することが可能となった。
 なお、培養中に上記支持プレート17を上下動させるようにすると、培養液の流動が促進されより効果的である。
When the cell aggregate 2 is arranged in the culture container 3 in this way, the culture container 3 is transferred to the incubator 6 by a robot or an operator's manual operation, and the cell aggregate 2 in the culture container 3 is removed. A culture step of culturing is performed.
First, when the culture vessel 3 is transferred to the incubator 6, the incubator 6 is separated from the isolator 5 and placed at a position separated from the isolator 5 to maintain the inside at a predetermined temperature and humidity, and a predetermined carbon dioxide gas. And maintain oxygen concentration.
In the culture vessel 3, when the cell aggregate 2 is cultured, the cell aggregates 2 of the adjacent holding portions H are fused with each other, so that the cell aggregate 2 is maintained in a planar arrangement. The fusion pad 4 as a collective structure can be obtained.
That is, since the movement of each cell aggregate 2 is regulated by the pin 16, the size of the formed fusion pad 4 can be made substantially the same as the size when the cell aggregate 2 is first arranged, It becomes possible to produce the fusion pad 4 having any shape as the cell aggregate 2 is arranged.
This is because the cell aggregate 2 grows or moves so as to be in close contact with the periphery of the pin 16 in contact with the cell aggregate 2 and fills the gap formed between the adjacent cell aggregates 2. As in the case where the cell agglomerates 2 are arranged in a plane and cultured without intervention, the overall dimensions hardly shrink.
At that time, since the gap g is formed below the cell aggregate 2, the culture solution is supplied between the fusion pad 4 and the installation surface 15 a of the pedestal 15, and the back side of the fusion pad 4. Can also be efficiently cultured.
That is, when the fusion pad 4 is produced by placing the cell aggregate 2 on the installation surface 15a, there is a problem that the culture solution does not sufficiently spread to the lower surface side of the cell aggregate 2 located in the center. By holding the cell aggregate 2 in a state in which the gap g is formed below, the cells located in the part can be well cultured.
If the support plate 17 is moved up and down during the culture, the flow of the culture solution is promoted, which is more effective.
 このようにして上記培養工程において培養液を交換しながら培養を進めると、細胞凝集塊2同士が融合し必要な大きさの癒合パッド4が得られるが、癒合パッド4は保持部Hに保持された状態となっており、換言すると癒合パッド4には上記ピン16が貫通したままとなっている。
 そこで、保持部Hに保持されている癒合パッド4を保持部Hから取り出す離脱工程を行う。具体的には、インキュベータ6をアイソレータ5に接続して培養容器3をアイソレータ5内部の上記培養容器支持部9に載置し、作業者もしくはロボット等によって上記下降位置に位置した支持プレート17を上昇位置に位置させる。
 これにより、癒合パッド4がピン16に沿って上昇され、図4(b)に示すように、上記支持プレート17が上方まで持ち上げられ、この状態で上記支持プレート17をクリップなどの固定具17bで固定するか、または支持プレート17を静かに下降位置へと移動させて、癒合パッド4を上記ピン16の先端部によって下方から支持させることにより、癒合パッド4を上記ピン16の上方に位置させる。
Thus, when culture | cultivation is advanced while exchanging a culture solution in the said culture | cultivation process, the cell aggregate 2 fuse | melts and the fusion pad 4 of a required magnitude | size is obtained, but the fusion pad 4 is hold | maintained at the holding part H. In other words, the pin 16 remains penetrating the fusion pad 4.
Therefore, a detachment process for taking out the fusion pad 4 held by the holding part H from the holding part H is performed. Specifically, the incubator 6 is connected to the isolator 5, the culture vessel 3 is placed on the culture vessel support portion 9 inside the isolator 5, and the support plate 17 positioned at the lowered position is raised by an operator or a robot or the like. To position.
As a result, the fusion pad 4 is raised along the pins 16 and the support plate 17 is lifted upward as shown in FIG. 4B. In this state, the support plate 17 is fixed with a fixture 17b such as a clip. The fusion pad 4 is positioned above the pin 16 by fixing or by gently moving the support plate 17 to the lowered position and supporting the fusion pad 4 from below by the tip of the pin 16.
 上記離脱工程により癒合パッド4をピン16の上方に位置させたら、続いて上記注入ノズル12によって癒合パッド4に開口している、上記ピン16による貫通孔4aに注入物を注入する注入工程を行う。
 具体的には、最初に上記カメラ28が培養容器支持部9の上方に移動して培養容器3内の癒合パッド4を撮影し、当該癒合パッド4の貫通孔4aの位置を認識する。
 続いて、上記注入ノズル移動手段13が培養容器支持部9の上方へと注入ノズル12を移動させ、さらに上記癒合パッド4の貫通孔4aの上方へ位置させた後、図6に示すように当該注入ノズル12の注入部12bを癒合パッド4に接近させる。
 この状態で注入ノズル12の注入部12bから注入物を放出すると、当該注入物は貫通孔4aの内部に注入される。
 このようにして、癒合パッド4の貫通孔4aに注入物が注入されると、そのまま癒合パッド4を使用するために、培養容器3から取り出して搬出用の容器に移して、アイソレータ5から搬出するようにしてもよいし、培養容器3を再びアイソレータ5からインキュベータ6へと移載して引き続き培養を継続して、上記貫通孔4aを完全に塞ぐようにしてもよい。
After the fusion pad 4 is positioned above the pin 16 by the above-described detachment process, an injection process for injecting an injection into the through-hole 4a by the pin 16 that is opened to the fusion pad 4 by the injection nozzle 12 is performed. .
Specifically, first, the camera 28 moves above the culture vessel support 9 to photograph the fusion pad 4 in the culture vessel 3 and recognize the position of the through hole 4 a of the fusion pad 4.
Subsequently, after the injection nozzle moving means 13 moves the injection nozzle 12 above the culture vessel support 9 and further positioned above the through-hole 4a of the fusion pad 4, as shown in FIG. The injection part 12 b of the injection nozzle 12 is brought close to the fusion pad 4.
When the injection is discharged from the injection portion 12b of the injection nozzle 12 in this state, the injection is injected into the through hole 4a.
In this way, when the injection is injected into the through-hole 4a of the fusion pad 4, in order to use the fusion pad 4 as it is, the fusion pad 4 is taken out from the culture vessel 3 and transferred to the carrying-out vessel and carried out from the isolator 5. Alternatively, the culture vessel 3 may be transferred again from the isolator 5 to the incubator 6 and the culture may be continued to completely close the through-hole 4a.
 図7、8は第2実施例としての細胞の集合構造体の作製方法を説明する図であり、本実施例で使用する培養容器3において、上記台座15に固定されるピン16は、癒合パッド4の中央部を保持する第1ピン群(16a)と、癒合パッド4の外周縁部を保持する黒色で示した第2ピン群(16b)とから構成されている。
 具体的には、図7において、上記第2ピン群を構成するピン16bは、最外周およびこれよりも一列内側に配置された額縁状に配置されている。このため、供給工程において培養容器3に細胞凝集塊2を収容すると、その最外周に配置された細胞凝集塊2は上記第2ピン群のピン16bによって形成された保持部Hに保持されるようになっている。
 また図8に示すように、上記第1ピン群を構成するピン16aは上記第2ピン群を構成するピン16bよりも短くなっており、上記細胞凝集塊2を保持する保持部Hの高さは上記第1ピン群のピン16aの先端部近傍の高さに設定されている。
7 and 8 are diagrams for explaining a method for producing a cell aggregate structure as a second embodiment. In the culture vessel 3 used in this embodiment, the pin 16 fixed to the pedestal 15 is a fusion pad. 4 comprises a first pin group (16a) that holds the central part of the pin 4 and a second pin group (16b) shown in black that holds the outer peripheral edge part of the fusion pad 4.
Specifically, in FIG. 7, the pins 16 b constituting the second pin group are arranged in a frame shape arranged on the outermost periphery and on the inner side in one row. For this reason, when the cell aggregate 2 is accommodated in the culture container 3 in the supply step, the cell aggregate 2 arranged on the outermost periphery thereof is held by the holding portion H formed by the pin 16b of the second pin group. It has become.
As shown in FIG. 8, the pin 16 a constituting the first pin group is shorter than the pin 16 b constituting the second pin group, and the height of the holding portion H that holds the cell aggregate 2. Is set to a height near the tip of the pin 16a of the first pin group.
 上記培養容器3を用いた細胞の集合構造体の作製方法を説明すると、図8(a)に示すように、供給工程では上記第1実施例と同様、上記第1、第2ピン群のピン16a、16bによって形成された保持部Hに細胞凝集塊2を保持させる。
 その後培養工程を行い、細胞凝集塊2がある程度融合して培養途中の癒合パッド4が形成されると、当該培養された癒合パッド4を収容した培養容器3をインキュベータ6からアイソレータ5へと移載する。
 そして図8(b)に示すように、下降位置に位置した支持プレート17を上下動させて、培養された癒合パッド4を第2ピン群のピン16bの先端部近傍の高さまで移動させ、上記第1ピン群のピン16aの保持部Hから取り出す離脱工程を行う。
 これにより、癒合パッド4は上記第2ピン群のピン16bによって支持された状態となり、当該癒合パッド4には第1ピン群のピン16aによる貫通孔4aが開口されている。
The method for producing a cell aggregate structure using the culture vessel 3 will be described. As shown in FIG. 8A, in the supplying step, the pins of the first and second pin groups are the same as in the first embodiment. The cell aggregate 2 is held in the holding portion H formed by 16a and 16b.
Thereafter, a culture process is performed, and when the cell aggregate 2 is fused to some extent to form the fusion pad 4 in the middle of the culture, the culture vessel 3 containing the cultured fusion pad 4 is transferred from the incubator 6 to the isolator 5. To do.
Then, as shown in FIG. 8B, the support plate 17 positioned at the lowered position is moved up and down to move the cultured fusion pad 4 to a height near the tip of the pin 16b of the second pin group, A detaching step for removing the pin 16a from the holding portion H of the first pin group is performed.
As a result, the fusion pad 4 is supported by the pin 16b of the second pin group, and the through hole 4a by the pin 16a of the first pin group is opened in the fusion pad 4.
 この状態において、上記注入ノズル12により、癒合パッド4の第1ピン群のピン16aによる貫通孔4aに注入物を注入する注入工程を行う。
 その後、上記癒合パッド4を再びアイソレータ5からインキュベータ6へと移動させて培養工程を再開し、引き続き培養を行うことで、上記貫通孔4aが培養された細胞によって埋められることとなる。
 その際に、貫通孔4aの大きさにもよるが、貫通孔4aが塞がる過程において癒合パッド4が中央部に向けて収縮し、湾曲する場合がある。
 これに対し、本実施例では、癒合パッド4の外周縁部を上記第2ピン群のピン16bによって保持しており、癒合パッド4の中央部の収縮が防止され、湾曲のない厚さが均一な癒合パッド4を得ることができる。
In this state, the injection nozzle 12 performs an injection process of injecting an injection into the through hole 4a by the pin 16a of the first pin group of the fusion pad 4.
Thereafter, the fusion pad 4 is moved again from the isolator 5 to the incubator 6 to resume the culturing process, followed by culturing, whereby the through-hole 4a is filled with the cultured cells.
At that time, although depending on the size of the through hole 4a, the fusion pad 4 may contract toward the center and bend in the process of closing the through hole 4a.
On the other hand, in this embodiment, the outer peripheral edge of the fusion pad 4 is held by the pin 16b of the second pin group, so that the central portion of the fusion pad 4 is prevented from contracting and the thickness without bending is uniform. Can be obtained.
 上記培養工程が終了し、上記癒合パッド4の中央部に形成された貫通孔4aが塞がると、上記培養容器3をインキュベータ6からアイソレータ5へと移動させて離脱工程を行う。
 具体的には、上記支持プレート17を再び下降位置から上昇位置まで上昇させて、癒合パッド4を上記第2ピン群の保持部Hより取り出す。
 このようにして得られた癒合パッド4の外周縁部には、それまで貫通していた上記第2ピン群のピン16bによる貫通孔4aが形成されているため、必要に応じて癒合パッド4の外周縁部を切断して除去し、中央部のみを回収するようにしてもよいし、さらに注入工程を実行して第1ピン群のピン16aによる貫通孔4aとは異なる注入物を注入するようにしてもよい。
 また、第1ピン群のピン16aによる貫通孔4aには注入物を注入をせずに塞いでしまい、第2ピン群のピン16bによる貫通孔4aに注入するようにすることも可能で、第1ピン群、第2ピン群を選択的に配置して、注入物の注入位置をデザインすることもできる。
When the culture process is completed and the through-hole 4a formed in the central portion of the fusion pad 4 is closed, the culture container 3 is moved from the incubator 6 to the isolator 5 to perform the detachment process.
Specifically, the support plate 17 is raised again from the lowered position to the raised position, and the fusion pad 4 is taken out from the holding portion H of the second pin group.
Since the through-hole 4a by the pin 16b of the said 2nd pin group penetrated until then is formed in the outer periphery part of the fusion pad 4 obtained in this way, the fusion pad 4 of the fusion pad 4 is needed as needed. The outer peripheral edge portion may be cut and removed, and only the central portion may be collected, or an injection process may be performed to inject an injection different from the through hole 4a by the pin 16a of the first pin group. It may be.
In addition, the through hole 4a formed by the pin 16a of the first pin group can be closed without being injected, and can be injected into the through hole 4a formed by the pin 16b of the second pin group. The injection position of the injection can be designed by selectively arranging the first pin group and the second pin group.
 図9は第3実施例としての細胞の集合構造体の作製方法を説明する図であり、細胞凝集塊2の直径が保持部Hの各対角位置のピン16の間隔よりも小径であり、当該細胞凝集塊2をピン16とピン16との間で保持できない場合に対応するものとなっている。
 具体的には、図10に示すように、作製される癒合パッド4を薄くするために、極力小さな細胞凝集塊2を用いる場合や、作製された細胞凝集塊2の大きさにばらつきがあって、ピン16とピン16とでは保持できずに落下してしまう細胞凝集塊2を含んでいる場合が想定される。
 そこで本実施例の供給工程では、図9(a)に示すように、ピン16の間を保持部Hとして細胞凝集塊2を収容させ、上記台座15の設置面15a上の下降位置に位置させた支持プレート17の上面に載置させて、個々の細胞凝集塊2を保持するようになっている。
 そして、上記細胞凝集塊2が支持プレート17に載置された状態のままで、当該培養容器3をインキュベータ6に移送して上記培養工程を開始し、図9(b)に示すように細胞凝集塊2が融合するまで培養を行う。
 細胞凝集塊2がある程度融合したら、上記支持プレート17を上記ピン16の基端側と先端側との間の中間位置まで上昇させて、上記複数のピン16を立設した設置面15aから離隔した位置を保持部Hとして細胞凝集塊2を保持させるようになっている。
 そして本実施例においても、所定の大きさの癒合パッド4が得られたら、培養工程から離脱工程および注入工程に移行する。
FIG. 9 is a diagram for explaining a method for producing a cell aggregate structure as a third embodiment, in which the diameter of the cell aggregate 2 is smaller than the interval between the pins 16 at each diagonal position of the holding portion H. This corresponds to the case where the cell aggregate 2 cannot be held between the pin 16 and the pin 16.
Specifically, as shown in FIG. 10, in order to make the produced fusion pad 4 thin, there is a variation in the case of using the smallest cell aggregate 2 or the size of the produced cell aggregate 2. It is assumed that the pin 16 and the pin 16 include a cell aggregate 2 that cannot be held and falls.
Therefore, in the supply process of the present embodiment, as shown in FIG. 9A, the cell aggregate 2 is accommodated with the space between the pins 16 as the holding portion H, and is positioned at the lowered position on the installation surface 15a of the pedestal 15. Each cell aggregate 2 is held by being placed on the upper surface of the support plate 17.
Then, while the cell aggregate 2 is placed on the support plate 17, the culture vessel 3 is transferred to the incubator 6 to start the culture process, and as shown in FIG. Incubate until mass 2 is fused.
When the cell aggregate 2 is fused to some extent, the support plate 17 is raised to an intermediate position between the proximal end side and the distal end side of the pin 16, and separated from the installation surface 15a where the plurality of pins 16 are erected. The cell aggregate 2 is held with the position being the holding portion H.
Also in this embodiment, when the fusion pad 4 having a predetermined size is obtained, the culture process shifts to the withdrawal process and the injection process.
 図11は第4実施例としての細胞の集合構造体の作製方法を説明する図であり、上記各実施例と異なり、培養容器3内に立設されたピン16の先端が鋭く尖って形成されており、細胞凝集塊2にピン16を貫通させて保持するものとなっている。
 細胞の集合構造体の作製装置1としては上記各実施例において使用されたものと同様のものを用いることができるが、上記吸引ノズル10によって上記細胞凝集塊2を上記ピン16で貫通させる際に、貫通したピン16が上記吸引部10b内に挿入されるようになっており、所定の位置で上記吸引ノズル10の下降を停止させて細胞凝集塊2を保持させるようになっている。
 このようにして細胞凝集塊2を保持させた場合においても、上記培養工程において隣接する保持部Hの細胞凝集塊2同士が融合し、上記各実施例と同様の癒合パッド4を得ることができる。
 また離脱工程においては、図11(b)に示すように支持プレート17を上方位置に移動させて、細胞凝集塊2を上記ピン16の上方に位置させることができ、注入工程において、上記注入ノズル12によって、各貫通孔4aに注入物を注入することができる。
 なお本実施例ではピン16が貫通した位置に貫通孔4aが形成され、注入ノズル12は当該ピン16の位置に移動して注入することとなる。
FIG. 11 is a diagram for explaining a method for producing a cell aggregate structure as a fourth embodiment. Unlike the above embodiments, the tip of a pin 16 erected in the culture vessel 3 is formed with a sharp point. The pin 16 is penetrated and held in the cell aggregate 2.
The cell assembly structure manufacturing apparatus 1 may be the same as that used in each of the above embodiments. However, when the cell aggregate 2 is penetrated by the pin 16 by the suction nozzle 10, The penetrating pin 16 is inserted into the suction portion 10b, and the lowering of the suction nozzle 10 is stopped at a predetermined position to hold the cell aggregate 2.
Even when the cell aggregate 2 is held in this manner, the cell aggregates 2 of the holding portions H adjacent to each other are fused in the culturing step, and the same fusion pad 4 as in the above embodiments can be obtained. .
Further, in the separation step, as shown in FIG. 11B, the support plate 17 can be moved to the upper position so that the cell aggregate 2 can be positioned above the pin 16. In the injection step, the injection nozzle 12, the injection can be injected into each through hole 4a.
In this embodiment, the through hole 4a is formed at the position where the pin 16 penetrates, and the injection nozzle 12 moves to the position of the pin 16 and injects.
 図12は第5実施例にかかる細胞の集合構造体の作製方法を説明する図となっており、上記第1~第4実施例において作製した細胞の集合構造体としての平面的な癒合パッド4に対し、本実施例ではZ方向に細胞凝集塊2を整列させた立体的な細胞の集合構造体を作製する方法を説明するものである。
 ただし、当該立体的な細胞の集合構造体を作製する場合であっても、上記第1実施例で使用した細胞の集合構造体の作製装置1と同様の構成を有した装置を使用することが可能であり、また略同様の工程を用いて作製することができるため、詳細な説明については省略する。
 図12に示す本実施例で使用する培養容器3において、上記ピン16の長さは所望される立体的な細胞の集合構造体の高さに応じて設定され、4本のピン16によって形成された保持部Hには細胞凝集塊2をZ方向に複数保持することが可能となっている。
 そして上記供給工程では、上記吸引ノズル10は予め設定された細胞凝集塊2の立体的な配置に基づいて、上記細胞凝集塊2を上記ピン16によって形成された保持部Hに供給する。
 具体的には、最初に培養容器支持部9が培養容器3をY方向に順次移動させて、最下段に配置すべき細胞凝集塊2を供給し、その後保持部Hに保持させた細胞凝集塊2の上部に順次細胞凝集塊2を供給するようにすればよい。
 この時も、上記各実施例と同様、最下段に位置する細胞凝集塊2の下方に隙間gを形成するようになっており、これにより立体的な細胞の集合構造体の下面への培養液の供給が行われるようにする。また、上記ピン16に支持された立体的な細胞の集合構造体の側面部分と培養容器3の側面部分との間にも隙間が形成されることから、細胞の集合構造体の側面部分にも培養液の供給が行われるようになっており、培養工程において立体的な集合構造体を形成することができる。
 そして本実施例においても、上記離脱工程および上記注入工程を行うことにより、保持部Hから取り出した集合構造体の貫通孔に上記注入ノズル12より注入物を注入することができる。この場合、上記注入ノズル12を集合構造体の貫通孔に挿入して、当該貫通孔4aの上下方向の所要の位置に上記注入物を注入するようにしても良い。
FIG. 12 is a diagram for explaining a method for producing a cell aggregate structure according to the fifth embodiment. The planar union pad 4 as the cell aggregate structure produced in the first to fourth embodiments is shown in FIG. On the other hand, in this embodiment, a method for producing a three-dimensional aggregate structure of cells in which cell aggregates 2 are aligned in the Z direction will be described.
However, even in the case of producing the three-dimensional cell assembly structure, it is possible to use an apparatus having the same configuration as the cell assembly structure preparation apparatus 1 used in the first embodiment. The detailed description is omitted because it is possible and can be manufactured using substantially the same process.
In the culture vessel 3 used in this embodiment shown in FIG. 12, the length of the pin 16 is set according to the desired height of the three-dimensional cell assembly, and is formed by four pins 16. The holding portion H can hold a plurality of cell aggregates 2 in the Z direction.
In the supplying step, the suction nozzle 10 supplies the cell aggregate 2 to the holding portion H formed by the pins 16 based on a preset three-dimensional arrangement of the cell aggregate 2.
Specifically, first, the culture vessel support unit 9 sequentially moves the culture vessel 3 in the Y direction to supply the cell aggregate 2 to be arranged at the bottom, and then the cell aggregate held in the holding unit H What is necessary is just to supply the cell aggregate 2 to the upper part of 2 sequentially.
At this time, as in each of the above embodiments, a gap g is formed below the cell aggregate 2 located at the lowermost stage, whereby the culture solution on the lower surface of the three-dimensional cell assembly structure is formed. To be supplied. Further, since a gap is also formed between the side surface portion of the three-dimensional cell assembly structure supported by the pin 16 and the side surface portion of the culture vessel 3, the side surface portion of the cell assembly structure is also formed. The culture solution is supplied, and a three-dimensional aggregate structure can be formed in the culture process.
Also in the present embodiment, the injection can be injected from the injection nozzle 12 into the through hole of the aggregate structure taken out from the holding portion H by performing the above-described detachment step and the above-described injection step. In this case, the injection nozzle 12 may be inserted into a through-hole of the assembly structure to inject the injection into a required position in the vertical direction of the through-hole 4a.
 なお、上記各実施例において、上記細胞凝集塊2を支持するピン16の配置としては、複数のピン16によって細胞凝集塊2を支持することが可能であれば、例えば6本のピン16で各細胞凝集塊2を囲繞するように配置してもよい。
 その場合、上記保持部Hは千鳥状に配置されることとなり、またこの配置を用いて上記第5実施例のような立体的な細胞の集合構造体を作製することも可能である。
In each of the above-described embodiments, the pin 16 that supports the cell aggregate 2 may be arranged with, for example, six pins 16 as long as the cell aggregate 2 can be supported by a plurality of pins 16. You may arrange | position so that the cell aggregate 2 may be surrounded.
In that case, the holding portions H are arranged in a staggered manner, and it is also possible to produce a three-dimensional aggregate structure of cells as in the fifth embodiment using this arrangement.
 さらに上記各実施例において、培養容器3に設けられるピン16の太さや、ピン16によって形成される保持部Hの大きさ、もしくは使用する細胞凝集塊2の直径に応じて、図13に示すようにさまざまな態様が考えられる。
 図13に示すピン16の直径は、上記各実施例で示したピン16の直径よりも大径であり、対角位置の2本のピン16の間隔よりも細胞凝集塊2の直径が大きい場合であっても、上記保持部Hに保持された隣接する細胞凝集塊2同士が接触しない場合を示している。
 このような場合であっても、上記培養工程において細胞凝集塊2が培養されて隣接する細胞凝集塊2が融合するため、上述したような癒合パッド4を得ることができ、またピン16が大径であるため、癒合パッド4に形成される貫通孔4aも大径となることから、当該貫通孔4aの内部に注入物を大量に注入することが可能となり、ピン16の太さによって注入量を規定することも可能である。
Further, in each of the above embodiments, as shown in FIG. 13, depending on the thickness of the pin 16 provided in the culture vessel 3, the size of the holding portion H formed by the pin 16, or the diameter of the cell aggregate 2 to be used. Various aspects are conceivable.
The diameter of the pin 16 shown in FIG. 13 is larger than the diameter of the pin 16 shown in the above embodiments, and the diameter of the cell aggregate 2 is larger than the interval between the two pins 16 at the diagonal positions. However, the case where the adjacent cell aggregate 2 hold | maintained at the said holding | maintenance part H does not contact is shown.
Even in such a case, since the cell aggregate 2 is cultured and the adjacent cell aggregate 2 is fused in the culturing step, the fusion pad 4 as described above can be obtained, and the pin 16 is large. Since the diameter of the through-hole 4a formed in the fusion pad 4 is large, it is possible to inject a large amount of an injection into the through-hole 4a. Can also be defined.
 上記癒合パッド4に形成された貫通孔4aに注入物として栄養成分や成長因子、増殖因子または薬物等を注入する場合、これら注入物の作用に応じて、例えば一つおきの貫通孔4aに注入して、効果を分散させるようにすることもでき、また癒合パッド4における特定の位置に集中する貫通孔4aにのみ注入物を注入して、癒合パッド4の特定の位置に作用性を持たせることも考えられる。
 また、癒合パッド4の所要の部分に血管が形成されるよう、注入物として血管を構成する細胞を含んだ細胞懸濁液を選択的に貫通孔4aに注入することも可能であり、癒合パッド4の用途に応じて、種類の異なる注入物を、貫通孔4aの位置を選択して注入することも可能である。
When injecting nutrients, growth factors, growth factors, drugs, or the like as injections into the through holes 4a formed in the fusion pad 4, depending on the action of these injections, for example, injection into every other through hole 4a Thus, the effect can be dispersed, and the injection is injected only into the through-holes 4a concentrated at a specific position in the fusion pad 4 so that the specific position of the fusion pad 4 is functional. It is also possible.
It is also possible to selectively inject the cell suspension containing the cells constituting the blood vessel as an injection into the through-hole 4a so that a blood vessel is formed in a required portion of the fusion pad 4. Depending on the application of 4, it is possible to inject different kinds of injections by selecting the positions of the through holes 4a.
 1 細胞の集合構造体の作製装置 2 細胞凝集塊
 3 培養容器          4 癒合パッド(細胞の集合構造体)
 10 吸引ノズル        12 注入ノズル
 16 ピン           17 支持プレート
 H 保持部           g 隙間
DESCRIPTION OF SYMBOLS 1 Production apparatus of cell aggregate structure 2 Cell aggregate 3 Culture container 4 Healing pad (cell aggregate structure)
10 Suction nozzle 12 Injection nozzle 16 Pin 17 Support plate H Holding part g Gap

Claims (6)

  1.  培養液を収容した培養容器の内部に複数の細胞凝集塊を配置し、上記複数の細胞凝集塊が培養されて相互に融合した細胞の集合構造体を作製する細胞の集合構造体の作製方法において、
     上記培養容器の内部に立設された複数のピンによって構成される保持部に細胞凝集塊を保持させる供給工程と、上記保持部に保持された細胞凝集塊を培養して上記集合構造体を形成する培養工程と、当該培養工程で形成された集合構造体を上記保持部から取り出す離脱工程と、当該離脱工程で取り出された集合構造体に開口する上記ピンによる貫通孔に注入物を注入する注入工程とを有することを特徴とする細胞の集合構造体の作製方法。
    In a method for producing a cell aggregate structure, a plurality of cell aggregates are arranged inside a culture vessel containing a culture solution, and a plurality of cell aggregates are cultured to produce a cell aggregate structure fused together ,
    A supply step of holding the cell aggregate in a holding part constituted by a plurality of pins standing inside the culture container, and culturing the cell aggregate held in the holding part to form the aggregate structure A culturing step, a detaching step of taking out the aggregate structure formed in the culturing step from the holding portion, and an injection for injecting an injection into the through-hole by the pin opening in the ensemble structure taken out in the detaching step A process for producing an aggregate structure of cells.
  2.  上記注入工程の後で、上記集合構造体を引き続き培養することを特徴とする請求項1に記載の細胞の集合構造体の作製方法。 The method for producing an aggregate structure of cells according to claim 1, wherein the aggregate structure is continuously cultured after the injection step.
  3.  培養液を収容した培養容器の内部に複数の細胞凝集塊を配置し、上記複数の細胞凝集塊が培養されて相互に融合した細胞の集合構造体を作製する細胞の集合構造体の作製装置において、
     上記培養容器の内部に設けられ複数のピンを立設させた培養保持具と、上記培養保持具のピンによって構成される複数の保持部に細胞凝集塊を保持させる供給手段と、上記培養保持具に保持された細胞凝集塊が培養されて形成された集合構造体を上記培養保持具の上記保持部から取り出す離脱手段と、当該取り出された集合構造体に開口する上記ピンによる貫通孔に注入物を注入する注入手段とを備えることを特徴とする細胞の集合構造体の作製装置。
    In a cell assembly structure manufacturing apparatus, a plurality of cell aggregates are arranged inside a culture vessel containing a culture solution, and the plurality of cell aggregates are cultured to produce a cell aggregate structure fused together ,
    A culture holder provided inside the culture vessel and provided with a plurality of pins, a supply means for holding a cell aggregate in a plurality of holding parts constituted by the pins of the culture holder, and the culture holder The detachment means for taking out the aggregate structure formed by culturing the cell agglomerates held in the cell from the holding part of the culture holder, and the injection into the through-hole by the pin opening to the extracted aggregate structure And an injecting means for injecting the cell.
  4.  上記培養保持具の保持部は上記複数のピンとピンとの間に形成され、上記供給手段はピンとピンとの間に細胞凝集塊を挟持または収容させることを特徴とする請求項3に記載の細胞の集合構造体の作製装置。 The cell assembly according to claim 3, wherein the holding part of the culture holder is formed between the plurality of pins and the supply means sandwiches or accommodates a cell aggregate between the pins. Structure manufacturing apparatus.
  5.  上記培養保持具の保持部は先端が鋭く形成された上記ピンによって構成され、上記供給手段は上記細胞凝集塊を上記ピンで貫通させるとともに、当該ピンの所定の位置で停止させることを特徴とする請求項3に記載の細胞の集合構造体の作製装置。 The holding part of the culture holder is constituted by the pin having a sharp tip, and the supply means penetrates the cell aggregate with the pin and stops at a predetermined position of the pin. The apparatus for producing a cell aggregate structure according to claim 3.
  6.  上記離脱手段は、上記培養保持具のピンに沿って移動可能な支持部材を備え、当該支持部材は、上記供給手段が保持部に細胞凝集塊を保持させる際はピンの基端側に位置し、細胞凝集塊が融合して形成された集合構造体を保持部から取り出す際にはピンの先端側に位置させることを特徴とする請求項3ないし請求項5のいずれかに記載の細胞の集合構造体の作製装置。 The detachment means includes a support member movable along the pin of the culture holder, and the support member is positioned on the proximal end side of the pin when the supply means holds the cell aggregate in the holding portion. The cell assembly according to any one of claims 3 to 5, wherein when the aggregate structure formed by fusing the cell agglomerates is taken out from the holding portion, the cell aggregate is located on the tip side of the pin. Structure manufacturing apparatus.
PCT/JP2017/038129 2016-12-05 2017-10-23 Method and apparatus both for producing cell aggregate structure WO2018105255A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016236183A JP6889363B2 (en) 2016-12-05 2016-12-05 Method and apparatus for preparing a cell aggregate structure
JP2016-236183 2016-12-05

Publications (1)

Publication Number Publication Date
WO2018105255A1 true WO2018105255A1 (en) 2018-06-14

Family

ID=62491880

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2017/038129 WO2018105255A1 (en) 2016-12-05 2017-10-23 Method and apparatus both for producing cell aggregate structure

Country Status (3)

Country Link
JP (1) JP6889363B2 (en)
TW (1) TW201831676A (en)
WO (1) WO2018105255A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008123614A1 (en) * 2007-03-30 2008-10-16 Kyushu University, National University Corporation Method for production of three-dimensional structure of cells
JP2013005751A (en) * 2011-06-24 2013-01-10 Saga Univ Apparatus for producing three-dimensional structure of cell
JP2017079719A (en) * 2015-10-29 2017-05-18 澁谷工業株式会社 Production method and production device of cell assembly structure

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102124331B (en) * 2008-06-24 2013-10-30 密苏里大学 Self-assembling multicellular bodies and methods of producing three-dimensional biological structure using same
US9442105B2 (en) * 2013-03-15 2016-09-13 Organovo, Inc. Engineered liver tissues, arrays thereof, and methods of making the same
WO2016046938A1 (en) * 2014-09-25 2016-03-31 株式会社サイフューズ Cell tray and device, method and system for producing cell structure
JP6534269B2 (en) * 2015-03-18 2019-06-26 富士フイルム株式会社 Tubular structure, method of producing cell structure, and method of producing tubular structure

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008123614A1 (en) * 2007-03-30 2008-10-16 Kyushu University, National University Corporation Method for production of three-dimensional structure of cells
JP2013005751A (en) * 2011-06-24 2013-01-10 Saga Univ Apparatus for producing three-dimensional structure of cell
JP2017079719A (en) * 2015-10-29 2017-05-18 澁谷工業株式会社 Production method and production device of cell assembly structure

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ITOH M. ET AL.: "Scaffold-Free Tubular Tissues Created by a Bio-3D Printer Undergo Remodeling and Endothelialization when Implanted in Rat Aortae", PLOS ONE, vol. 10, no. 9, 1 September 2015 (2015-09-01), pages 1 - 15, XP055491551 *
S AKAGUCHI, KATSUHISA ET AL.: "Development on bioreactor for building 3-dimensional tissue", JAPANESE JOURNAL OF ARTIFICIAL ORGANS, vol. 44, no. 1, 2015, pages 57 - 61 *
SAKAI, HIDEAKI ET AL.: "Regenerative medicine by Japanese first-world' s first '' cell sheet engineering", TECHNOLOGY, vol. 271, 2013, pages 44 - 52 *

Also Published As

Publication number Publication date
TW201831676A (en) 2018-09-01
JP2018088879A (en) 2018-06-14
JP6889363B2 (en) 2021-06-18

Similar Documents

Publication Publication Date Title
JP6882658B2 (en) Method and apparatus for preparing a cell aggregate structure
US8198086B2 (en) Method for production of three-dimensional structure of cells
CN113773959B (en) Organoid culture chip and organoid culture method
JP2016093149A (en) Cell culture apparatus, and cell culture method
US9194865B2 (en) Object selecting device and object selecting method
EP1992685A1 (en) Novel cell culture method and methods of producing and collecting cell masses using the same
CN103261393A (en) Culture substrate and culture sheet
JP6715330B2 (en) Cell three-dimensional structuring method and three-dimensional structuring system
US11898132B2 (en) Bioreactor and method of forming complex three-dimensional tissue constructs
CN109072157A (en) Cell liquid transfer device and Rotary cell culture device between container used in a large amount of cell culture systems, the system
JP6814380B2 (en) Method for producing cell spheroids
US20120058560A1 (en) Bioreactor System
KR20180117179A (en) 3D printing of cellularization scaffolds
EP3162890A1 (en) Method and apparatus for producing cell mass structure
TW201718847A (en) Apparatus for producing cell mass sheet and method for producing cell mass sheet
KR101341572B1 (en) 3-dimensional cell culture instrument using hollow tube and 3-dimensional cell culture method using the same
CN110213964A (en) It is prepared using the individuation cell biological of closing minicell culture systems
WO2018105255A1 (en) Method and apparatus both for producing cell aggregate structure
JP6982231B2 (en) Equipment for making a cell aggregate structure
DE19808055A1 (en) Tissue engineering procedure extracting and culturing cells with mechanical stimulation to simulate in-vivo growth
JP6880384B2 (en) Cell mass sheet manufacturing equipment
CN114958725B (en) Three-dimensional cell sphere hanging drop culture and co-culture method based on hydrophilic-hydrophobic array chip
JP7037038B2 (en) Equipment for making a cell aggregate structure
JP7041346B2 (en) Cell culture method using gelatin support
CN219032208U (en) 3D cell culture prevents cell adherence growth structure and auxiliary placement device

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17878136

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17878136

Country of ref document: EP

Kind code of ref document: A1